{"gene":"PAM","run_date":"2026-04-29T11:37:57","timeline":{"discoveries":[{"year":1990,"finding":"Human PAM (peptidylglycine α-amidating monooxygenase) cDNA was cloned from a thyroid carcinoma library. A truncated form lacking the C-terminal transmembrane domain was functionally expressed in COS cells, producing a soluble, active enzyme with a 20-fold increase in amidating activity over controls, establishing that the transmembrane domain is dispensable for catalytic activity.","method":"cDNA cloning, heterologous expression in COS cells, enzyme activity assay","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 1 — functional expression with activity measurement; single lab study","pmids":["2357221"],"is_preprint":false},{"year":1992,"finding":"The rat PAM gene consists of 27 exons spanning >160 kb. Alternative splicing within the PHM region generates soluble monofunctional PHM proteins; alternative splicing at the transmembrane domain exon generates integral membrane or soluble bifunctional PAM proteins; and a single alternatively spliced exon between PHM and PAL domains permits endoproteolytic separation of the two catalytic activities. The human PAM gene was mapped to chromosome 5q.","method":"Genomic cloning, Southern blotting, exon mapping, hybrid cell panel analysis","journal":"Molecular endocrinology","confidence":"High","confidence_rationale":"Tier 1 — direct genomic and cDNA structural analysis with functional annotation; replicated across species","pmids":["1448112"],"is_preprint":false},{"year":1993,"finding":"PAM is a multifunctional type-1 integral membrane protein containing two sequential catalytic domains: peptidylglycine α-hydroxylating monooxygenase (PHM), which performs copper- and ascorbate-dependent α-hydroxylation of peptidylglycine substrates, and peptidyl-α-hydroxyglycine α-amidating lyase (PAL), which cleaves the N–C bond to produce amidated peptide and glyoxylate. Tissue-specific alternative splicing generates integral membrane or soluble forms, and the cytosolic C-terminal domain contains routing information for retrieval from the cell surface.","method":"Protein purification, enzyme assays, alternative splicing analysis, transfected cell expression","journal":"Protein science","confidence":"High","confidence_rationale":"Tier 1 — biochemical reconstitution of two-step reaction with domain identification; foundational review synthesizing multiple experiments","pmids":["8518727"],"is_preprint":false},{"year":1993,"finding":"Endoproteolytic removal of the C-terminal region from bifunctional soluble PAM-3 (PHM+PAL) shifted the PHM pH optimum to more alkaline, increased PHM kcat, and decreased its Km for peptidylglycine substrate, while PAL activity was unaffected. This demonstrated that the PAL domain and C-terminal region modulate PHM catalytic properties within the bifunctional protein.","method":"Protein purification from transfected HEK-293 cells, limited endoproteolysis, N-terminal sequencing, enzyme kinetics","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro biochemical assay with defined proteolytic manipulation and kinetic measurements","pmids":["8486658"],"is_preprint":false},{"year":1995,"finding":"The cytosolic domain of integral membrane PAM is phosphorylated on Ser932 and Ser937 by protein kinase C (PKC). Phosphorylation at Ser937 is required for correct post-endocytic routing of PAM: a Ser937→Ala mutant is abnormally targeted to lysosomes upon internalization rather than being recycled, establishing a role for PKC-mediated phosphorylation in PAM trafficking.","method":"Metabolic [32P] labeling, truncation mutagenesis, site-directed mutagenesis (Ser937→Ala), subcellular fractionation, PAM antibody internalization assay in AtT-20 and HEK-293 cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 — mutagenesis combined with functional trafficking readout in endocrine cells","pmids":["8530412"],"is_preprint":false},{"year":1997,"finding":"Using yeast two-hybrid screening, the cytosolic routing domain of PAM was found to interact with P-CIP10 (later named Kalirin), a 217-kDa cytosolic protein containing nine spectrin-like repeats and Dbl homology/pleckstrin homology domains typical of GDP/GTP exchange factors. Kalirin binds Rac1 but not RhoA or Cdc42, and co-expression with PAM in corticotrope tumor cells accelerates PAM turnover and promotes longer, more branched neuritic processes, suggesting Kalirin links PAM lumenal activity to cytoskeletal regulation.","method":"Yeast two-hybrid, GST pull-down, co-expression in AtT-20 cells, neurite morphology assay, GTPase binding assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — yeast two-hybrid confirmed by pull-down with functional cellular phenotype; multiple orthogonal methods","pmids":["9139723"],"is_preprint":false},{"year":1998,"finding":"P-CIP1, a novel 435-amino-acid cytosolic protein identified by yeast two-hybrid as a PAM cytosolic domain interactor, associates specifically with wild-type PAM-1 but not with trafficking-defective PAM-1 mutants. P-CIP1 localizes to recycling endosomes (overlapping with secretory carrier membrane proteins, transferrin, and Rab11), suggesting it regulates PAM trafficking through the endosomal pathway.","method":"Yeast two-hybrid, in vitro pull-down, co-expression in endocrine and fibroblast cells, immunofluorescence colocalization with endosomal markers","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2–3 — yeast two-hybrid with localization data; no direct rescue experiment","pmids":["9837933"],"is_preprint":false},{"year":2000,"finding":"In Drosophila, PHM (the α-hydroxylating monooxygenase domain/activity of PAM) is the rate-limiting enzyme for C-terminal α-amidation of neuropeptides. PHM null mutants lack amidated peptides but retain non-amidated neuropeptide precursors and other biosynthetic enzymes. PHM mutants display phenotypes resembling ecdysone-response gene mutations, including failure to molt and pupal lethality, establishing that PHM-dependent peptide amidation is essential for developmental transitions between stages.","method":"Genetic null mutants, enzyme activity assay, neuropeptide immunostaining, transgenic rescue with inducible PHM transgene","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 1–2 — genetic null with biochemical validation and transgenic rescue in Drosophila ortholog","pmids":["10993678"],"is_preprint":false},{"year":2003,"finding":"Pam (PAM/MYCBP2) was found to associate with the tuberin–hamartin (TSC2–TSC1) complex in rat brain. The C-terminus of Pam containing the RING zinc finger domain binds directly to tuberin. In cortical neurons, Pam co-localizes with tuberin and hamartin in neurites and growth cones. Genetic studies in Drosophila showed that the Pam ortholog Highwire (HIW) can negetically interact with the Tsc1·Tsc2 complex, consistent with PAM acting as a potential E3 ubiquitin ligase that regulates TSC1/TSC2 complex stability.","method":"Co-immunoprecipitation from rat brain, yeast two-hybrid domain mapping, immunofluorescence colocalization in cortical neurons, Drosophila genetic epistasis","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2–3 — Co-IP plus genetic epistasis but ubiquitin ligase activity not directly reconstituted","pmids":["14559897"],"is_preprint":false},{"year":2004,"finding":"PAM (Protein Associated with Myc/MYCBP2) is localized to the endoplasmic reticulum in HeLa cells. Treatment with sphingosine-1-phosphate (S1P), purified from serum, induces translocation of PAM to the plasma membrane within 15 min, persisting up to 120 min. This PAM translocation mediates a late phase (20–240 min) of adenylyl cyclase inhibition that is PAM-dependent, distinct from an early Gi-mediated phase. Thus PAM acts as the longest-lasting non-transcriptional inhibitor of adenylyl cyclase activity known, enabling sustained inhibition of cAMP signaling.","method":"Subcellular fractionation, immunofluorescence microscopy, adenylyl cyclase activity assay, S1P purification, siRNA knockdown","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 — direct localization experiment with functional consequence (adenylyl cyclase inhibition), siRNA validation, multiple orthogonal methods","pmids":["15257286"],"is_preprint":false},{"year":2008,"finding":"The RCC1 (Regulator of Chromatin Condensation) domain of PAM (MYCBP2) was identified as a binding partner of the K+/Cl− cotransporter KCC2 via yeast two-hybrid screening. The RCC1 domain of PAM binds to a 20-amino-acid region on the KCC2 C-terminus, as confirmed by GST pull-down and co-immunoprecipitation in HEK293 cells. Co-expression of RCC1/PAM with KCC2 increases KCC2-mediated 86Rb+/K+ flux, and a point mutant in the KCC2 binding region abolishes both PAM interaction and N-ethylmaleimide activation of KCC2, establishing PAM as a positive modulator of KCC2 cotransporter function.","method":"Yeast two-hybrid, GST pull-down, co-immunoprecipitation in HEK293, 86Rb+/K+ uptake assay, site-directed mutagenesis","journal":"Cellular physiology and biochemistry","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal binding assays plus functional transport assay with mutagenesis validation","pmids":["18769030"],"is_preprint":false},{"year":2010,"finding":"E3 ligases Arf-bp1 and Pam (MYCBP2) co-purify with the circadian heme receptor Rev-erbα and are required for its ubiquitination and proteasomal degradation. RNAi-mediated depletion of Arf-bp1 or Pam stabilizes Rev-erbα protein and protects it from degradation triggered by lithium (a GSK3β inhibitor) or serum shock. This degradation pathway controls expression of Rev-erbα-regulated clock genes including Bmal1 and modulates circadian function in mouse hepatoma cells.","method":"Affinity purification/co-IP, ubiquitination assay, RNAi knockdown, cycloheximide chase, circadian gene expression analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — Co-IP, ubiquitination assay, and RNAi functional rescue with circadian phenotype; multiple orthogonal methods","pmids":["20534529"],"is_preprint":false},{"year":2010,"finding":"The cytosolic domain (CD) of PAM (amidating monooxygenase) is phosphorylated by U2AF homology motif kinase 1 (Uhmk1/J83). Uhmk1 is concentrated in the nucleus but cycles rapidly between nucleus and cytosol. Endoproteolytic cleavage of integral membrane PAM releases a soluble CD fragment that localizes to the nucleus. Phosphomimetic mutations in PAM-CD or overexpression of active Uhmk1 reduces nuclear localization of PAM-CD. Nuclear PAM-CD increases expression of a subset of genes including aquaporin 1 (Aqp1); this relationship is confirmed in vivo in PAM heterozygous mice. Thus, a retrograde signaling pathway exists from secretory granules to the nucleus via PAM-CD cleavage.","method":"Subcellular fractionation, phosphomimetic mutagenesis, Uhmk1 overexpression/knockdown, microarray gene expression analysis, in vivo PAM heterozygous mouse model","journal":"Molecular endocrinology","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods including mutagenesis, in vivo validation in heterozygous mice, and microarray; moderate-strong evidence","pmids":["20573687"],"is_preprint":false},{"year":2015,"finding":"PAM (amidating monooxygenase) is an evolutionarily ancient bifunctional enzyme: the PHM domain uses copper, ascorbate (vitamin C), and molecular oxygen to hydroxylate the Cα of C-terminal glycine-extended peptide substrates; the PAL domain then cleaves the N–Cα bond to yield amidated product and glyoxylate. Crystal structures of both catalytic cores have been determined, revealing metal-coordination and substrate-binding mechanisms. PAM is also found in cilia and in Chlamydomonas (a unicellular eukaryote), indicating a role beyond peptide processing. The cytosolic domain, though intrinsically disordered, is essential for PAM trafficking. Evidence also supports a role for PAM in copper homeostasis and in retrograde signaling from the secretory pathway lumen to the nucleus.","method":"Crystal structure determination, enzymatic assays, knockout mouse model (lethal at mid-gestation), phylogenetic survey, cellular localization studies","journal":"Journal of molecular endocrinology","confidence":"High","confidence_rationale":"Tier 1 — crystal structures plus multiple in vivo and biochemical validations; comprehensive review of original experimental findings","pmids":["26667899"],"is_preprint":false},{"year":2016,"finding":"Neuronal differentiation increases copper demand within the secretory pathway. This is facilitated in part by upregulation of the copper transporter ATP7A and its chaperone Atox1. PAM (peptidylglycine α-amidating monooxygenase), a copper-dependent enzyme in the secretory pathway, is among the copper-dependent enzymes whose expression is elevated in differentiated neurons, directly linking copper availability to PAM-dependent amidation capacity.","method":"Quantitative real-time imaging of copper/glutathione redox state, qPCR, western blotting in differentiating neuronal cells","journal":"Nature communications","confidence":"Medium","confidence_rationale":"Tier 3 — expression upregulation measured in differentiation context; PAM's copper dependency established but mechanism not directly probed in this study","pmids":["26879543"],"is_preprint":false},{"year":2018,"finding":"PAM (MYCBP2) forms a noncanonical SCF-like ubiquitin ligase complex containing FBXO45 and SKP1 but lacking CUL1. FBXO45 is required for assembly of the PAM/FBXO45/SKP1 complex, not merely for substrate recognition. SKP1 acts as an auxiliary component of the substrate recognition module, enhancing FBXO45 binding to NMNAT2. PAM polyubiquitinates NMNAT2 and promotes its proteasomal degradation, establishing the biochemical mechanism by which PAM/PHR proteins regulate axon degeneration through NMNAT2.","method":"Affinity purification/co-immunoprecipitation, in vitro ubiquitination assay, proteasome inhibitor treatment, cycloheximide chase, domain-specific interaction mapping in C. elegans and human cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 — in vitro ubiquitination assay plus Co-IP complex characterization and degradation assay; multiple orthogonal methods","pmids":["29997255"],"is_preprint":false},{"year":2018,"finding":"Missense variants in PAM (amidating monooxygenase) — p.Asp563Gly and p.Ser539Trp — are associated with type 2 diabetes risk and impact negatively on overall PAM amidating activity via defects in protein expression and catalytic function. PAM deficiency in a human β-cell model and primary cadaveric islets reduces insulin content and alters dynamics of insulin secretion, establishing a direct role for PAM-mediated peptide amidation in β-cell function.","method":"Functional variant analysis (Western blot, amidation activity assay in cell lysates and serum), human β-cell model (EndoC-βH1), primary human islets, insulin secretion assay","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 1–2 — direct enzymatic activity measurement, loss-of-function in human β-cells and primary islets, multiple orthogonal methods","pmids":["30054598","24464100"],"is_preprint":false},{"year":2023,"finding":"Germline loss-of-function variants in PAM (amidating monooxygenase) are enriched in individuals with pituitary hypersecretion (including growth hormone excess and Cushing disease). Seven heterozygous likely pathogenic SNVs were identified and functionally validated: in vitro assays showed reduced protein expression, abnormal splicing (minigene assay), and decreased amidating activity in cell lysates and patient serum, confirming deleterious effects on PAM function and linking PAM to pituitary tumor/hypersecretion pathogenesis.","method":"Germline sequencing, CNV analysis, Western blotting, minigene splicing assay, amidation activity assay in cell lysates and serum, UK Biobank exome analysis","journal":"Frontiers in endocrinology","confidence":"High","confidence_rationale":"Tier 2 — multiple functional validation methods across several variants; large-scale epidemiological confirmation in UK Biobank","pmids":["37388215"],"is_preprint":false}],"current_model":"PAM encodes a bifunctional, copper- and ascorbate-dependent type-1 integral membrane enzyme whose luminal PHM domain hydroxylates C-terminal glycine-extended peptide substrates and whose PAL domain cleaves the product to yield amidated peptides and glyoxylate; its intrinsically disordered cytosolic domain is phosphorylated by PKC (on Ser937, governing endosomal recycling) and by Uhmk1, interacts with trafficking proteins (Kalirin/P-CIP10, P-CIP1) and KCC2, and can be endoproteolytically released to signal retrogradely to the nucleus; the MYCBP2/PAM paralog (Protein Associated with Myc) functions as a non-canonical SCF E3 ubiquitin ligase (with FBXO45/SKP1 but lacking CUL1) that polyubiquitinates NMNAT2 to regulate axon degeneration, inhibits adenylyl cyclase activity downstream of sphingosine-1-phosphate signaling, targets Rev-erbα for degradation to modulate circadian rhythms, and interacts with the TSC1–TSC2 complex; loss-of-function variants in the amidating PAM reduce β-cell insulin content and are associated with type 2 diabetes and pituitary hypersecretion."},"narrative":{"teleology":[{"year":1990,"claim":"Cloning of human PAM cDNA and demonstration that a soluble truncated form retains full amidating activity established that the transmembrane domain is dispensable for catalysis, framing the protein as a modular enzyme.","evidence":"cDNA cloning from thyroid carcinoma library, heterologous expression in COS cells with enzyme activity assay","pmids":["2357221"],"confidence":"Medium","gaps":["Single lab observation without independent replication at that time","Physiological relevance of soluble forms unclear"]},{"year":1992,"claim":"Genomic characterization revealed a 27-exon gene with extensive alternative splicing that generates soluble versus membrane-bound and monofunctional versus bifunctional isoforms, explaining the tissue-specific diversity of PAM products.","evidence":"Genomic cloning, exon mapping, and Southern blotting in rat; chromosomal mapping in human","pmids":["1448112"],"confidence":"High","gaps":["Tissue-specific splicing regulation mechanisms undefined","Functional significance of each splice form not individually tested"]},{"year":1993,"claim":"Biochemical reconstitution defined the two-step reaction — PHM-catalyzed copper/ascorbate-dependent α-hydroxylation followed by PAL-catalyzed lyase cleavage — and showed that the PAL domain allosterically modulates PHM kinetics within the bifunctional protein.","evidence":"Protein purification, limited endoproteolysis, N-terminal sequencing, and enzyme kinetics in HEK-293 cells","pmids":["8518727","8486658"],"confidence":"High","gaps":["No atomic-resolution structure at this stage","In vivo relevance of intramolecular domain modulation not tested"]},{"year":1995,"claim":"Identification of PKC-dependent phosphorylation at Ser937 as a trafficking switch — preventing lysosomal mis-sorting after endocytosis — established that the cytosolic domain actively controls PAM's itinerary through the endosomal system.","evidence":"Metabolic 32P labeling, Ser937→Ala mutagenesis, antibody internalization assay in AtT-20 and HEK-293 cells","pmids":["8530412"],"confidence":"High","gaps":["Identity of the phosphatase reversing Ser937 phosphorylation unknown","Kinase specificity beyond PKC not explored"]},{"year":1997,"claim":"Discovery that the PAM cytosolic domain binds Kalirin, a Rac1-specific GEF, linked luminal enzymatic processing to cytoskeletal remodeling and neurite morphogenesis, revealing a signaling role beyond peptide amidation.","evidence":"Yeast two-hybrid, GST pull-down, co-expression in AtT-20 cells with neurite morphology readout","pmids":["9139723"],"confidence":"High","gaps":["Whether Kalirin interaction is direct or scaffolded in vivo not settled","Rac1-dependent downstream effectors not mapped"]},{"year":1998,"claim":"Identification of P-CIP1 as a second cytosolic-domain interactor localized to recycling endosomes extended the model that PAM's cytoplasmic tail coordinates vesicular trafficking.","evidence":"Yeast two-hybrid, pull-down, immunofluorescence colocalization with endosomal markers","pmids":["9837933"],"confidence":"Medium","gaps":["No direct rescue experiment to confirm functional role of P-CIP1 in PAM recycling","Endogenous stoichiometry of P-CIP1–PAM complex not determined"]},{"year":2000,"claim":"Genetic ablation of the Drosophila PHM ortholog proved that PHM-dependent amidation is essential for organism-level viability, with null mutants failing to complete developmental molting transitions.","evidence":"PHM null mutants, neuropeptide immunostaining, transgenic rescue in Drosophila","pmids":["10993678"],"confidence":"High","gaps":["Specific amidated peptide substrates driving lethality not identified","Mammalian in vivo essentiality confirmed later but not here"]},{"year":2010,"claim":"The demonstration that endoproteolytic release of PAM's cytosolic domain allows nuclear translocation and gene regulation (e.g., Aqp1), modulated by Uhmk1 phosphorylation and confirmed in PAM heterozygous mice, established a retrograde secretory-granule-to-nucleus signaling pathway.","evidence":"Subcellular fractionation, phosphomimetic mutagenesis, microarray, PAM heterozygous mouse model","pmids":["20573687"],"confidence":"High","gaps":["Full repertoire of nuclear gene targets unknown","Mechanism of PAM-CD-dependent transcriptional activation unclear"]},{"year":2015,"claim":"Crystal structures of both PHM and PAL catalytic cores resolved metal coordination and substrate-binding geometry; phylogenetic surveys extending to Chlamydomonas and cilia indicated PAM's evolutionary antiquity and roles beyond neuropeptide processing.","evidence":"X-ray crystallography, enzymatic assays, knockout mouse (mid-gestation lethal), phylogenetic analysis","pmids":["26667899"],"confidence":"High","gaps":["Ciliary function of PAM mechanistically uncharacterized","How PAM contributes to copper homeostasis remains unclear"]},{"year":2018,"claim":"Functional validation of PAM missense variants (p.Asp563Gly, p.Ser539Trp) linked reduced amidating activity to lower β-cell insulin content and type 2 diabetes risk, directly connecting PAM enzymology to metabolic disease.","evidence":"Variant activity assays, EndoC-βH1 human β-cell model, primary human islets, insulin secretion measurements","pmids":["30054598","24464100"],"confidence":"High","gaps":["Which specific amidated peptides in β-cells are functionally critical remains undefined","Heterozygous loss-of-function penetrance and modifier genes not characterized"]},{"year":2023,"claim":"Enrichment of germline loss-of-function PAM variants in pituitary hypersecretion patients, validated by splicing and activity assays, expanded PAM's disease spectrum beyond diabetes to neuroendocrine tumor predisposition.","evidence":"Germline sequencing, minigene splicing assay, amidation activity assay, UK Biobank exome association","pmids":["37388215"],"confidence":"High","gaps":["Mechanism linking reduced amidation to pituitary hyperplasia/hypersecretion not delineated","Whether somatic second hits contribute to tumorigenesis unknown"]},{"year":null,"claim":"Key unresolved questions include the identities of the specific amidated substrates driving β-cell and pituitary phenotypes, the molecular mechanism of PAM's ciliary function, and how the retrograde nuclear signaling pathway converges on transcription.","evidence":"","pmids":[],"confidence":"Low","gaps":["Critical amidated substrates in β-cells and pituitary not identified","PAM ciliary function mechanistically undefined","Transcription factor partners of nuclear PAM-CD unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016491","term_label":"oxidoreductase activity","supporting_discovery_ids":[0,2,3,7,13,16]},{"term_id":"GO:0016829","term_label":"lyase activity","supporting_discovery_ids":[2,3,13]},{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[2,13]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[1,2,4]},{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[4,6]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[12]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[4,6,12,13]},{"term_id":"GO:0005929","term_label":"cilium","supporting_discovery_ids":[13]}],"pathway":[{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[2,3,13,16]},{"term_id":"R-HSA-9609507","term_label":"Protein localization","supporting_discovery_ids":[4,6,12]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[7]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[16,17]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[5,12]}],"complexes":[],"partners":["KALRN","PCIP1","UHMK1"],"other_free_text":[]},"mechanistic_narrative":"PAM (peptidyl-glycine alpha-amidating monooxygenase) is a bifunctional, copper- and ascorbate-dependent type-1 integral membrane enzyme that catalyzes the two-step C-terminal amidation of secretory peptides: its PHM domain α-hydroxylates glycine-extended substrates, and its PAL domain cleaves the intermediate to yield amidated peptide and glyoxylate [PMID:8518727, PMID:26667899]. Alternative splicing of the 27-exon gene generates soluble or membrane-anchored isoforms, and the intrinsically disordered cytosolic domain undergoes PKC-dependent phosphorylation at Ser937 to direct endosomal recycling rather than lysosomal degradation, while Uhmk1-mediated phosphorylation regulates nuclear import of an endoproteolytically released cytosolic fragment that activates gene expression retrogradely from secretory granules [PMID:8530412, PMID:20573687]. PAM-dependent peptide amidation is essential for insect development, mammalian embryogenesis, and pancreatic β-cell insulin content; loss-of-function variants reduce amidating activity and are associated with type 2 diabetes risk and pituitary hypersecretion [PMID:10993678, PMID:30054598, PMID:37388215]."},"prefetch_data":{"uniprot":{"accession":"P19021","full_name":"Peptidyl-glycine alpha-amidating monooxygenase","aliases":[],"length_aa":973,"mass_kda":108.3,"function":"Bifunctional enzyme that catalyzes amidation of the C-terminus of proteins (PubMed:12699694, PubMed:2357221). Alpha-amidation is present at the C-terminus of many endocrine hormones and neuropeptides and is required for their activity (PubMed:1575450). C-terminal amidation also takes place in response to protein fragmentation triggered by oxidative stress, promoting degradation of amidated protein fragments by the proteasome (PubMed:2207077). Alpha-amidation involves two sequential reactions, both of which are catalyzed by separate catalytic domains of the enzyme (PubMed:12699694). The first step, catalyzed by peptidyl alpha-hydroxylating monooxygenase (PHM) domain, is the copper-, ascorbate-, and O2- dependent stereospecific hydroxylation (with S stereochemistry) at the alpha-carbon (C-alpha) of the C-terminal glycine of the peptidylglycine substrate (PubMed:12699694). The second step, catalyzed by the peptidylglycine amidoglycolate lyase (PAL) domain, is the zinc-dependent cleavage of the N-C-alpha bond, producing the alpha-amidated peptide and glyoxylate (PubMed:12699694). Similarly, catalyzes the two-step conversion of an N-fatty acylglycine to a primary fatty acid amide and glyoxylate (By similarity)","subcellular_location":"Secreted","url":"https://www.uniprot.org/uniprotkb/P19021/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/PAM","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/PAM","total_profiled":1310},"omim":[{"mim_id":"621357","title":"CYSTEINE-RICH TAIL PROTEIN 1; CYSRT1","url":"https://www.omim.org/entry/621357"},{"mim_id":"619804","title":"DEAFNESS, AUTOSOMAL DOMINANT 82; DFNA82","url":"https://www.omim.org/entry/619804"},{"mim_id":"618535","title":"ECTODERMAL DYSPLASIA 15, HYPOHIDROTIC/HAIR TYPE; ECTD15","url":"https://www.omim.org/entry/618535"},{"mim_id":"617166","title":"DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 47; DEE47","url":"https://www.omim.org/entry/617166"},{"mim_id":"614041","title":"RB TRANSCRIPTIONAL COREPRESSOR 1; RB1","url":"https://www.omim.org/entry/614041"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Golgi apparatus","reliability":"Approved"},{"location":"Cytosol","reliability":"Approved"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"epididymis","ntpm":691.0},{"tissue":"heart muscle","ntpm":1159.0}],"url":"https://www.proteinatlas.org/search/PAM"},"hgnc":{"alias_symbol":["PAL","PHM","PAM-1"],"prev_symbol":[]},"alphafold":{"accession":"P19021","domains":[{"cath_id":"2.60.120.310","chopping":"50-194","consensus_level":"high","plddt":87.5937,"start":50,"end":194},{"cath_id":"2.60.120.230","chopping":"197-347","consensus_level":"high","plddt":92.3007,"start":197,"end":347},{"cath_id":"2.120.10.30","chopping":"502-811","consensus_level":"medium","plddt":91.6288,"start":502,"end":811}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P19021","model_url":"https://alphafold.ebi.ac.uk/files/AF-P19021-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P19021-F1-predicted_aligned_error_v6.png","plddt_mean":71.69},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=PAM","jax_strain_url":"https://www.jax.org/strain/search?query=PAM"},"sequence":{"accession":"P19021","fasta_url":"https://rest.uniprot.org/uniprotkb/P19021.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P19021/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P19021"}},"corpus_meta":[{"pmid":"26098369","id":"PMC_26098369","title":"Engineered CRISPR-Cas9 nucleases with altered PAM specificities.","date":"2015","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/26098369","citation_count":1268,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29512652","id":"PMC_29512652","title":"Evolved Cas9 variants with broad PAM compatibility and high DNA specificity.","date":"2018","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/29512652","citation_count":1152,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25079318","id":"PMC_25079318","title":"Structural basis of PAM-dependent target DNA recognition by the Cas9 endonuclease.","date":"2014","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/25079318","citation_count":975,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28581492","id":"PMC_28581492","title":"Engineered Cpf1 variants with altered PAM specificities.","date":"2017","source":"Nature biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/28581492","citation_count":324,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27041224","id":"PMC_27041224","title":"Identifying and Visualizing Functional PAM Diversity across CRISPR-Cas Systems.","date":"2016","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/27041224","citation_count":251,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27984729","id":"PMC_27984729","title":"PAM-Dependent Target DNA Recognition and Cleavage by C2c1 CRISPR-Cas Endonuclease.","date":"2016","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/27984729","citation_count":208,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33483498","id":"PMC_33483498","title":"CRISPR technologies and the search for the PAM-free nuclease.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/33483498","citation_count":205,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8244975","id":"PMC_8244975","title":"PAM, a novel plasminogen-binding protein from Streptococcus pyogenes.","date":"1993","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8244975","citation_count":184,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30109815","id":"PMC_30109815","title":"PAM identification by CRISPR-Cas effector complexes: diversified mechanisms and structures.","date":"2018","source":"RNA biology","url":"https://pubmed.ncbi.nlm.nih.gov/30109815","citation_count":178,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15036564","id":"PMC_15036564","title":"Oxidative stress-induced apoptosis is associated with alterations in mitochondrial caspase activity and Bcl-2-dependent alterations in mitochondrial pH (pHm).","date":"2004","source":"Brain research bulletin","url":"https://pubmed.ncbi.nlm.nih.gov/15036564","citation_count":165,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18679731","id":"PMC_18679731","title":"Phenylalanine ammonia-lyase (PAL) and cinnamate 4-hydroxylase (C4H) and catechins (flavan-3-ols) accumulation in tea.","date":"2008","source":"Functional & integrative genomics","url":"https://pubmed.ncbi.nlm.nih.gov/18679731","citation_count":133,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27916599","id":"PMC_27916599","title":"Deciphering, Communicating, and Engineering the CRISPR PAM.","date":"2016","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/27916599","citation_count":125,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28652856","id":"PMC_28652856","title":"Photo-affinity labeling (PAL) in chemical proteomics: a handy tool to investigate protein-protein interactions (PPIs).","date":"2017","source":"Proteome science","url":"https://pubmed.ncbi.nlm.nih.gov/28652856","citation_count":122,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26990991","id":"PMC_26990991","title":"Structural Basis for the Altered PAM Specificities of Engineered CRISPR-Cas9.","date":"2016","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/26990991","citation_count":118,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2318966","id":"PMC_2318966","title":"Expression and modulation of nerve growth factor in murine keratinocytes (PAM 212).","date":"1990","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/2318966","citation_count":110,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32393822","id":"PMC_32393822","title":"An engineered ScCas9 with broad PAM range and high specificity and activity.","date":"2020","source":"Nature biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/32393822","citation_count":103,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32472934","id":"PMC_32472934","title":"The multifarious roles of Tol-Pal in Gram-negative bacteria.","date":"2020","source":"FEMS microbiology reviews","url":"https://pubmed.ncbi.nlm.nih.gov/32472934","citation_count":97,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32424114","id":"PMC_32424114","title":"A Cas9 with PAM recognition for adenine dinucleotides.","date":"2020","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/32424114","citation_count":91,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30928636","id":"PMC_30928636","title":"Genome Engineering in Rice Using Cas9 Variants that Recognize NG PAM Sequences.","date":"2019","source":"Molecular plant","url":"https://pubmed.ncbi.nlm.nih.gov/30928636","citation_count":88,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20534529","id":"PMC_20534529","title":"E3 ligases Arf-bp1 and Pam mediate lithium-stimulated degradation of the circadian heme receptor Rev-erb alpha.","date":"2010","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/20534529","citation_count":86,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2987932","id":"PMC_2987932","title":"Coding sequences for vasoactive intestinal peptide and PHM-27 peptide are located on two adjacent exons in the human genome.","date":"1985","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/2987932","citation_count":82,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29883605","id":"PMC_29883605","title":"Cas4 Nucleases Define the PAM, Length, and Orientation of DNA Fragments Integrated at CRISPR Loci.","date":"2018","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/29883605","citation_count":80,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33636398","id":"PMC_33636398","title":"Engineered prime editors with PAM flexibility.","date":"2021","source":"Molecular therapy : the journal of the American Society of Gene Therapy","url":"https://pubmed.ncbi.nlm.nih.gov/33636398","citation_count":79,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28595896","id":"PMC_28595896","title":"Structural Basis for the Altered PAM Recognition by Engineered CRISPR-Cpf1.","date":"2017","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/28595896","citation_count":78,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10515919","id":"PMC_10515919","title":"In vitro characterization of peptidoglycan-associated lipoprotein (PAL)-peptidoglycan and PAL-TolB interactions.","date":"1999","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/10515919","citation_count":77,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10993678","id":"PMC_10993678","title":"PHM is required for normal developmental transitions and for biosynthesis of secretory peptides in Drosophila.","date":"2000","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/10993678","citation_count":74,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26667899","id":"PMC_26667899","title":"60 YEARS OF POMC: From POMC and α-MSH to PAM, molecular oxygen, copper, and vitamin C.","date":"2015","source":"Journal of molecular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/26667899","citation_count":71,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"14559897","id":"PMC_14559897","title":"Pam and its ortholog highwire interact with and may negatively regulate the TSC1.TSC2 complex.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14559897","citation_count":69,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22759610","id":"PMC_22759610","title":"The phenylalanine ammonia lyase (PAL) gene family shows a gymnosperm-specific lineage.","date":"2012","source":"BMC genomics","url":"https://pubmed.ncbi.nlm.nih.gov/22759610","citation_count":66,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29941359","id":"PMC_29941359","title":"Phenylalanine ammonia lyase (PAL): From discovery to enzyme substitution therapy for phenylketonuria.","date":"2018","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/29941359","citation_count":62,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9497374","id":"PMC_9497374","title":"Molecular co-operation between protein PAM and streptokinase for plasmin acquisition by Streptococcus pyogenes.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9497374","citation_count":62,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"3018707","id":"PMC_3018707","title":"The receptors of the VIP family peptides (VIP, secretin, GRF, PHI, PHM, GIP, glucagon and oxyntomodulin). Specificities and identity.","date":"1986","source":"Peptides","url":"https://pubmed.ncbi.nlm.nih.gov/3018707","citation_count":60,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32130891","id":"PMC_32130891","title":"High-Throughput Screens of PAM-Flexible Cas9 Variants for Gene Knockout and Transcriptional Modulation.","date":"2020","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/32130891","citation_count":54,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"6086627","id":"PMC_6086627","title":"Cyclic AMP regulation of pro-vasoactive intestinal polypeptide/PHM-27 synthesis in human neuroblastoma cells.","date":"1984","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/6086627","citation_count":54,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29885909","id":"PMC_29885909","title":"PAM-Antagonists: A Better Way to Block Pathological Receptor Signaling?","date":"2018","source":"Trends in pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/29885909","citation_count":53,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37794046","id":"PMC_37794046","title":"PAM-flexible genome editing with an engineered chimeric Cas9.","date":"2023","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/37794046","citation_count":49,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30445722","id":"PMC_30445722","title":"Safety Studies of Pneumococcal Endolysins Cpl-1 and Pal.","date":"2018","source":"Viruses","url":"https://pubmed.ncbi.nlm.nih.gov/30445722","citation_count":48,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15257286","id":"PMC_15257286","title":"PAM mediates sustained inhibition of cAMP signaling by sphingosine-1-phosphate.","date":"2004","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/15257286","citation_count":47,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2422707","id":"PMC_2422707","title":"Effects of VIP, PHM and substance P on blood vessels and secretory elements of the human submandibular gland.","date":"1986","source":"Regulatory peptides","url":"https://pubmed.ncbi.nlm.nih.gov/2422707","citation_count":46,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23392249","id":"PMC_23392249","title":"Genetic determinants of PAM-dependent DNA targeting and pre-crRNA processing in Sulfolobus islandicus.","date":"2013","source":"RNA biology","url":"https://pubmed.ncbi.nlm.nih.gov/23392249","citation_count":46,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22349733","id":"PMC_22349733","title":"Characterization, high-resolution mapping and differential expression of three homologous PAL genes in Coffea canephora Pierre (Rubiaceae).","date":"2012","source":"Planta","url":"https://pubmed.ncbi.nlm.nih.gov/22349733","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33974322","id":"PMC_33974322","title":"PAL-mediated SA biosynthesis pathway contributes to nematode resistance in wheat.","date":"2021","source":"The Plant journal : for cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/33974322","citation_count":41,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32070055","id":"PMC_32070055","title":"Simulated Microgravity Influences VEGF, MAPK, and PAM Signaling in Prostate Cancer Cells.","date":"2020","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32070055","citation_count":41,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31655558","id":"PMC_31655558","title":"Expression patterns of two pal genes of Pleurotus ostreatus across developmental stages and under heat stress.","date":"2019","source":"BMC microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/31655558","citation_count":41,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23017408","id":"PMC_23017408","title":"Phenylalanine ammonia lyase (PAL) enzyme activity and antioxidant properties of some cyanobacteria isolates.","date":"2012","source":"Food chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23017408","citation_count":41,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29997255","id":"PMC_29997255","title":"PAM forms an atypical SCF ubiquitin ligase complex that ubiquitinates and degrades NMNAT2.","date":"2018","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/29997255","citation_count":41,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26354441","id":"PMC_26354441","title":"Structure and function of the Escherichia coli Tol-Pal stator protein TolR.","date":"2015","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26354441","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26070140","id":"PMC_26070140","title":"Characterisation of the willow phenylalanine ammonia-lyase (PAL) gene family reveals expression differences compared with poplar.","date":"2015","source":"Phytochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26070140","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33547443","id":"PMC_33547443","title":"Scalable characterization of the PAM requirements of CRISPR-Cas enzymes using HT-PAMDA.","date":"2021","source":"Nature protocols","url":"https://pubmed.ncbi.nlm.nih.gov/33547443","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20573687","id":"PMC_20573687","title":"Signaling from the secretory granule to the nucleus: Uhmk1 and PAM.","date":"2010","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/20573687","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35552388","id":"PMC_35552388","title":"Genome editing in animals with minimal PAM CRISPR-Cas9 enzymes.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/35552388","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30937444","id":"PMC_30937444","title":"Cas4-Cas1 fusions drive efficient PAM selection and control CRISPR adaptation.","date":"2019","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/30937444","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10987251","id":"PMC_10987251","title":"Morphology and DNA content analysis in the evaluation of first trimester placentas for partial hydatidiform mole (PHM).","date":"2000","source":"Human pathology","url":"https://pubmed.ncbi.nlm.nih.gov/10987251","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32329776","id":"PMC_32329776","title":"Characterization of Cas12a nucleases reveals diverse PAM profiles between closely-related orthologs.","date":"2020","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/32329776","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31342294","id":"PMC_31342294","title":"DNA vaccine encoding OmpA and Pal from Acinetobacter baumannii efficiently protects mice against pulmonary infection.","date":"2019","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/31342294","citation_count":36,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40262634","id":"PMC_40262634","title":"Custom CRISPR-Cas9 PAM variants via scalable engineering and machine learning.","date":"2025","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/40262634","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31036811","id":"PMC_31036811","title":"Structural basis for the promiscuous PAM recognition by Corynebacterium diphtheriae Cas9.","date":"2019","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/31036811","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33420918","id":"PMC_33420918","title":"Efficient and high-fidelity base editor with expanded PAM compatibility for cytidine dinucleotide.","date":"2021","source":"Science China. Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33420918","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"6548020","id":"PMC_6548020","title":"Production of VIP- and PHM (human PHI)-related peptides in human neuroblastoma cells.","date":"1984","source":"Peptides","url":"https://pubmed.ncbi.nlm.nih.gov/6548020","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24173806","id":"PMC_24173806","title":"QUIRKY interacts with STRUBBELIG and PAL OF QUIRKY to regulate cell growth anisotropy during Arabidopsis gynoecium development.","date":"2013","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/24173806","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36247561","id":"PMC_36247561","title":"Phylogenomic analysis of phenylalanine ammonia-lyase (PAL) multigene family and their differential expression analysis in wheat (Triticum aestivum L.) suggested their roles during different stress responses.","date":"2022","source":"Frontiers in plant science","url":"https://pubmed.ncbi.nlm.nih.gov/36247561","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2366002","id":"PMC_2366002","title":"Monoclonal antibody PAL-M1 recognizes the transferrin receptor and is a progression marker in melanocytic lesions.","date":"1990","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/2366002","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37697004","id":"PMC_37697004","title":"Molecular basis and engineering of miniature Cas12f with C-rich PAM specificity.","date":"2023","source":"Nature chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/37697004","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21155570","id":"PMC_21155570","title":"Design and synthesis of an orally active metabotropic glutamate receptor subtype-2 (mGluR2) positive allosteric modulator (PAM) that decreases cocaine self-administration in rats.","date":"2010","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21155570","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2839091","id":"PMC_2839091","title":"Complete nucleotide sequence of human vasoactive intestinal peptide/PHM-27 gene and its inducible promoter.","date":"1988","source":"Annals of the New York Academy of Sciences","url":"https://pubmed.ncbi.nlm.nih.gov/2839091","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35797934","id":"PMC_35797934","title":"PCDetection: PolyA-CRISPR/Cas12a-based miRNA detection without PAM restriction.","date":"2022","source":"Biosensors & bioelectronics","url":"https://pubmed.ncbi.nlm.nih.gov/35797934","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34687846","id":"PMC_34687846","title":"Cas12a variants designed for lower genome-wide off-target effect through stringent PAM recognition.","date":"2021","source":"Molecular therapy : the journal of the American Society of Gene Therapy","url":"https://pubmed.ncbi.nlm.nih.gov/34687846","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34824292","id":"PMC_34824292","title":"Engineering a PAM-flexible SpdCas9 variant as a universal gene repressor.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/34824292","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"3840886","id":"PMC_3840886","title":"Evidence for common precursors but differential processing of VIP and PHM in VIP-producing tumors.","date":"1985","source":"Peptides","url":"https://pubmed.ncbi.nlm.nih.gov/3840886","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35335056","id":"PMC_35335056","title":"Roles of the Tol/Pal System in Bacterial Pathogenesis and Its Application to Antibacterial Therapy.","date":"2022","source":"Vaccines","url":"https://pubmed.ncbi.nlm.nih.gov/35335056","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36581623","id":"PMC_36581623","title":"Genome-wide studies of PAL genes in sorghum and their responses to aphid infestation.","date":"2022","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/36581623","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38942756","id":"PMC_38942756","title":"PAM-flexible Engineered FnCas9 variants for robust and ultra-precise genome editing and diagnostics.","date":"2024","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/38942756","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28344037","id":"PMC_28344037","title":"Methods for decoding Cas9 protospacer adjacent motif (PAM) sequences: A brief overview.","date":"2017","source":"Methods (San Diego, Calif.)","url":"https://pubmed.ncbi.nlm.nih.gov/28344037","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37814209","id":"PMC_37814209","title":"Genome-wide identification and expression analysis of phenylalanine ammonia-lyase (PAL) family in rapeseed (Brassica napus L.).","date":"2023","source":"BMC plant biology","url":"https://pubmed.ncbi.nlm.nih.gov/37814209","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26754817","id":"PMC_26754817","title":"The Pal pathway required for ambient pH adaptation regulates growth, conidiation, and osmotolerance of Beauveria bassiana in a pH-dependent manner.","date":"2016","source":"Applied microbiology and biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/26754817","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35308353","id":"PMC_35308353","title":"Force-Generation by the Trans-Envelope Tol-Pal System.","date":"2022","source":"Frontiers in microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/35308353","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32494703","id":"PMC_32494703","title":"Programming PAM antennae for efficient CRISPR-Cas9 DNA editing.","date":"2020","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/32494703","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34874112","id":"PMC_34874112","title":"Compact SchCas9 Recognizes the Simple NNGR PAM.","date":"2021","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/34874112","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36268581","id":"PMC_36268581","title":"A new family of CRISPR-type V nucleases with C-rich PAM recognition.","date":"2022","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/36268581","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33441553","id":"PMC_33441553","title":"Engineered dual selection for directed evolution of SpCas9 PAM specificity.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/33441553","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12036515","id":"PMC_12036515","title":"Developmental expression of PAM (protein associated with MYC) in the rodent brain.","date":"2002","source":"Brain research. Developmental brain research","url":"https://pubmed.ncbi.nlm.nih.gov/12036515","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31603896","id":"PMC_31603896","title":"Molecular basis for the PAM expansion and fidelity enhancement of an evolved Cas9 nuclease.","date":"2019","source":"PLoS biology","url":"https://pubmed.ncbi.nlm.nih.gov/31603896","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32241913","id":"PMC_32241913","title":"Quantification of the affinities of CRISPR-Cas9 nucleases for cognate protospacer adjacent motif (PAM) sequences.","date":"2020","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/32241913","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1662940","id":"PMC_1662940","title":"Introduction of Tn916 and pAM beta 1 into Streptococcus bovis JB1 by conjugation.","date":"1991","source":"Applied and environmental microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/1662940","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35666156","id":"PMC_35666156","title":"Molecular Mechanism of D1135E-Induced Discriminated CRISPR-Cas9 PAM Recognition.","date":"2022","source":"Journal of chemical information and modeling","url":"https://pubmed.ncbi.nlm.nih.gov/35666156","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8020060","id":"PMC_8020060","title":"Location of PHM/VIP mRNA in human gastrointestinal tract detected by in situ hybridization.","date":"1994","source":"Cell and tissue research","url":"https://pubmed.ncbi.nlm.nih.gov/8020060","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11985791","id":"PMC_11985791","title":"Enhanced expression of neuron-specific enolase (NSE) in pyothorax-associated lymphoma (PAL).","date":"2002","source":"Japanese journal of cancer research : Gann","url":"https://pubmed.ncbi.nlm.nih.gov/11985791","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20599902","id":"PMC_20599902","title":"The PAM-1 aminopeptidase regulates centrosome positioning to ensure anterior-posterior axis specification in one-cell C. elegans embryos.","date":"2010","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/20599902","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29037946","id":"PMC_29037946","title":"Discovery of a novel 2,4-dimethylquinoline-6-carboxamide M4 positive allosteric modulator (PAM) chemotype via scaffold hopping.","date":"2017","source":"Bioorganic & medicinal chemistry letters","url":"https://pubmed.ncbi.nlm.nih.gov/29037946","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33679835","id":"PMC_33679835","title":"Biochemical Characterization and Differential Expression of PAL Genes Associated With \"Translocated\" Peach/Plum Graft-Incompatibility.","date":"2021","source":"Frontiers in plant science","url":"https://pubmed.ncbi.nlm.nih.gov/33679835","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38010352","id":"PMC_38010352","title":"Completely Free from PAM Limitations: Asymmetric RPA with CRISPR/Cas12a for Nucleic Acid Assays.","date":"2023","source":"ACS sensors","url":"https://pubmed.ncbi.nlm.nih.gov/38010352","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36378874","id":"PMC_36378874","title":"Expanding the Scope of Bacterial CRISPR Activation with PAM-Flexible dCas9 Variants.","date":"2022","source":"ACS synthetic biology","url":"https://pubmed.ncbi.nlm.nih.gov/36378874","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15719499","id":"PMC_15719499","title":"PAM-1, a natural human IgM antibody as new tool for detection of breast and prostate precursors.","date":"2004","source":"Human antibodies","url":"https://pubmed.ncbi.nlm.nih.gov/15719499","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31101493","id":"PMC_31101493","title":"Identification and immunological evaluation of novel TLR2 agonists through structure optimization of Pam3CSK4.","date":"2019","source":"Bioorganic & medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/31101493","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18769030","id":"PMC_18769030","title":"The RCC1 domain of protein associated with Myc (PAM) interacts with and regulates KCC2.","date":"2008","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/18769030","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39003282","id":"PMC_39003282","title":"TracrRNA reprogramming enables direct PAM-independent detection of RNA with diverse DNA-targeting Cas12 nucleases.","date":"2024","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/39003282","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8844771","id":"PMC_8844771","title":"Vascular effects and cyclic AMP production produced by VIP, PHM, PHV, PACAP-27, PACAP-38, and NPY on rabbit ovarian artery.","date":"1996","source":"Peptides","url":"https://pubmed.ncbi.nlm.nih.gov/8844771","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37903458","id":"PMC_37903458","title":"Expression profiling of the phenylalanine ammonia-lyase (PAL) gene family in ginkgo biloba L.","date":"2023","source":"Plant signaling & behavior","url":"https://pubmed.ncbi.nlm.nih.gov/37903458","citation_count":13,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37388215","id":"PMC_37388215","title":"Germline loss-of-function PAM variants are enriched in subjects with pituitary hypersecretion.","date":"2023","source":"Frontiers in endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/37388215","citation_count":13,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31400605","id":"PMC_31400605","title":"Improving Editing Efficiency for the Sequences with NGH PAM Using xCas9-Derived Base Editors.","date":"2019","source":"Molecular therapy. Nucleic acids","url":"https://pubmed.ncbi.nlm.nih.gov/31400605","citation_count":13,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17081983","id":"PMC_17081983","title":"Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.","date":"2006","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/17081983","citation_count":2861,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19571808","id":"PMC_19571808","title":"Common variants conferring risk of schizophrenia.","date":"2009","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/19571808","citation_count":1320,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26186194","id":"PMC_26186194","title":"The BioPlex Network: A Systematic Exploration of the Human Interactome.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26186194","citation_count":1118,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16344560","id":"PMC_16344560","title":"Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes.","date":"2005","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/16344560","citation_count":409,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19199708","id":"PMC_19199708","title":"Proteomic analysis of human parotid gland exosomes by multidimensional protein identification technology (MudPIT).","date":"2009","source":"Journal of proteome research","url":"https://pubmed.ncbi.nlm.nih.gov/19199708","citation_count":237,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"24464100","id":"PMC_24464100","title":"Identification of low-frequency and rare sequence variants associated with elevated or reduced risk of type 2 diabetes.","date":"2014","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24464100","citation_count":231,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20351714","id":"PMC_20351714","title":"Poor replication of candidate genes for major depressive disorder using genome-wide association data.","date":"2010","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/20351714","citation_count":220,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8518727","id":"PMC_8518727","title":"Peptidylglycine alpha-amidating monooxygenase: a multifunctional protein with catalytic, processing, and routing domains.","date":"1993","source":"Protein science : a publication of the Protein Society","url":"https://pubmed.ncbi.nlm.nih.gov/8518727","citation_count":206,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15840729","id":"PMC_15840729","title":"Scanning the human proteome for calmodulin-binding proteins.","date":"2005","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/15840729","citation_count":139,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23533145","id":"PMC_23533145","title":"In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.","date":"2013","source":"Proteomics","url":"https://pubmed.ncbi.nlm.nih.gov/23533145","citation_count":138,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23376485","id":"PMC_23376485","title":"Proteomic analysis of podocyte exosome-enriched fraction from normal human urine.","date":"2013","source":"Journal of proteomics","url":"https://pubmed.ncbi.nlm.nih.gov/23376485","citation_count":126,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9139723","id":"PMC_9139723","title":"Kalirin, a cytosolic protein with spectrin-like and GDP/GTP exchange factor-like domains that interacts with peptidylglycine alpha-amidating monooxygenase, an integral membrane peptide-processing enzyme.","date":"1997","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9139723","citation_count":113,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20379614","id":"PMC_20379614","title":"Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score.","date":"2010","source":"Molecular medicine (Cambridge, Mass.)","url":"https://pubmed.ncbi.nlm.nih.gov/20379614","citation_count":108,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26879543","id":"PMC_26879543","title":"Neuronal differentiation is associated with a redox-regulated increase of copper flow to the secretory pathway.","date":"2016","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/26879543","citation_count":96,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"30054598","id":"PMC_30054598","title":"Type 2 diabetes risk alleles in PAM impact insulin release from human pancreatic β-cells.","date":"2018","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/30054598","citation_count":66,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28700943","id":"PMC_28700943","title":"A Role for Mitochondrial Translation in Promotion of Viability in K-Ras Mutant Cells.","date":"2017","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/28700943","citation_count":64,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"2357221","id":"PMC_2357221","title":"Human peptidylglycine alpha-amidating monooxygenase: cDNA, cloning and functional expression of a truncated form in COS cells.","date":"1990","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/2357221","citation_count":60,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29987050","id":"PMC_29987050","title":"Estrogen-regulated feedback loop limits the efficacy of estrogen receptor-targeted breast cancer therapy.","date":"2018","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/29987050","citation_count":59,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8619474","id":"PMC_8619474","title":"A \"double adaptor\" method for improved shotgun library construction.","date":"1996","source":"Analytical biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8619474","citation_count":53,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"1448112","id":"PMC_1448112","title":"The multifunctional peptidylglycine alpha-amidating monooxygenase gene: exon/intron organization of catalytic, processing, and routing domains.","date":"1992","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/1448112","citation_count":52,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"36138187","id":"PMC_36138187","title":"NUDT21 limits CD19 levels through alternative mRNA polyadenylation in B cell acute lymphoblastic leukemia.","date":"2022","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/36138187","citation_count":46,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8486658","id":"PMC_8486658","title":"Use of endoproteases to identify catalytic domains, linker regions, and functional interactions in soluble peptidylglycine alpha-amidating monooxygenase.","date":"1993","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8486658","citation_count":45,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9110174","id":"PMC_9110174","title":"Large-scale concatenation cDNA sequencing.","date":"1997","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/9110174","citation_count":45,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8530412","id":"PMC_8530412","title":"Phosphorylation of the cytosolic domain of peptidylglycine alpha-amidating monooxygenase.","date":"1995","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8530412","citation_count":33,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9837933","id":"PMC_9837933","title":"P-CIP1, a novel protein that interacts with the cytosolic domain of peptidylglycine alpha-amidating monooxygenase, is associated with endosomes.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9837933","citation_count":30,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":44610,"output_tokens":2944,"usd":0.088995},"stage2":{"model":"claude-opus-4-6","input_tokens":6304,"output_tokens":2660,"usd":0.14703},"total_usd":0.565019,"stage1_batch_id":"msgbatch_012ZiiCUBfB62NCTQd4Bk1Jo","stage2_batch_id":"msgbatch_01Xuqq9aUHoQouS7UVGZNStZ","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":57864,"output_tokens":8782,"usd":0.152661},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":9266,"output_tokens":2849,"usd":0.176333}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2015,\n      \"finding\": \"PAM (peptidylglycine α-amidating monooxygenase) is the sole enzyme catalyzing C-terminal α-amidation of secreted peptides, proceeding via two steps: PHM (peptidylglycine α-hydroxylating monooxygenase) catalyzes copper- and ascorbate-dependent α-hydroxylation of the peptidylglycine substrate, and PAL (peptidyl-α-hydroxyglycine α-amidating lyase) cleaves the N-C bond to produce amidated product and glyoxylate. Both catalytic activities reside in the luminal domain of the type 1 integral membrane protein PAM, and crystal structures of both catalytic cores have been determined.\",\n      \"method\": \"Biochemical purification, cloning, in vitro enzymatic assay, X-ray crystallography, mutagenesis\",\n      \"journal\": \"Journal of molecular endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted enzymatic activity, crystal structures of both catalytic domains, replicated across decades of work\",\n      \"pmids\": [\"26667899\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"PAM (MYCBP2) functions as an E3 ubiquitin ligase that, together with Arf-bp1, is co-purified with Rev-erbα and is required for its ubiquitination and proteasomal degradation. RNAi-mediated depletion of PAM stabilizes Rev-erbα protein, blocks lithium- or serum shock-triggered degradation, and alters expression of Rev-erbα-regulated Clock genes in mouse hepatoma cells.\",\n      \"method\": \"Co-purification, RNA interference, ubiquitination assay, proteasome inhibitor studies, circadian gene expression analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal co-purification plus functional RNAi rescue with defined cellular phenotype\",\n      \"pmids\": [\"20534529\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Human PAM (MYCBP2) forms a non-canonical SCF-like ubiquitin ligase complex containing the F-box protein FBXO45 and SKP1 but lacking CUL1. FBXO45 is required for complex assembly rather than solely for substrate recognition, and SKP1 enhances FBXO45 binding to the substrate NMNAT2. PAM polyubiquitinates NMNAT2 in vitro and regulates its proteasomal degradation.\",\n      \"method\": \"Co-immunoprecipitation, in vitro ubiquitination assay, proteasome inhibition, domain mapping by pulldown, genetic interaction studies\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro ubiquitination reconstitution plus multiple orthogonal biochemical methods in one study\",\n      \"pmids\": [\"29997255\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"PAM (Protein Associated with Myc/MYCBP2) is localized at the endoplasmic reticulum in resting HeLa cells and is recruited to the plasma membrane upon sphingosine-1-phosphate (S1P) stimulation. PAM translocation to the plasma membrane causes sustained late-phase inhibition of adenylyl cyclase activity (20–240 min), making it the longest-acting non-transcriptional regulator of cAMP signaling known. The initial (1–10 min) adenylyl cyclase inhibition is Gi-mediated and PAM-independent.\",\n      \"method\": \"Subcellular fractionation, immunofluorescence localization, adenylyl cyclase activity assay, S1P purification and identification, RNAi knockdown\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct localization tied to functional adenylyl cyclase inhibition with orthogonal methods\",\n      \"pmids\": [\"15257286\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Mammalian PAM (MYCBP2) physically associates with the tuberin-hamartin (TSC1-TSC2) complex in the brain; the C-terminal RING zinc finger domain of PAM binds to tuberin. PAM co-localizes with tuberin and hamartin in neurites and growth cones of cortical neurons. Genetic epistasis in Drosophila shows that the PAM ortholog Highwire (HIW) negatively regulates the Tsc1-Tsc2 complex.\",\n      \"method\": \"Co-immunoprecipitation, domain pulldown mapping, immunofluorescence co-localization, Drosophila genetic epistasis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — reciprocal Co-IP plus genetic epistasis in ortholog, but PAM function not fully reconstituted in vitro\",\n      \"pmids\": [\"14559897\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"The cytosolic domain (CD) of PAM is phosphorylated by Uhmk1 (U2AF homology motif kinase 1) and other Ser/Thr kinases. Endoproteolytic cleavage of PAM releases a soluble CD fragment that translocates to the nucleus. Nuclear localization of PAM-CD is reduced by phosphomimetic mutations and by overexpression of active Uhmk1. PAM-CD modulates gene expression, including increasing Aqp1 mRNA levels in AtT-20 cells and in vivo in mice, defining a retrograde signaling pathway from secretory granules to the nucleus.\",\n      \"method\": \"Phosphorylation assay, live imaging/fractionation of nuclear localization, phosphomimetic mutagenesis, microarray gene expression, heterozygous PAM knockout mice, Uhmk1 overexpression\",\n      \"journal\": \"Molecular endocrinology (Baltimore, Md.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (mutagenesis, fractionation, in vivo mouse genetics) in one study confirming retrograde signaling mechanism\",\n      \"pmids\": [\"20573687\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"The RCC1 domain of PAM (MYCBP2) binds to the carboxyl terminus of the K-Cl cotransporter KCC2, as demonstrated by yeast two-hybrid, GST pulldown, and co-immunoprecipitation. Co-expression of RCC1/PAM with KCC2 in HEK293 cells increases KCC2-mediated K+/Rb+ transport. A point mutation that abolishes RCC1/PAM binding to KCC2 also eliminates N-ethylmaleimide activation of KCC2.\",\n      \"method\": \"Yeast two-hybrid, GST pulldown, co-immunoprecipitation, 86Rb/K+ uptake assay, point mutagenesis\",\n      \"journal\": \"Cellular physiology and biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — multiple binding assays plus functional transport assay with mutagenesis in single study\",\n      \"pmids\": [\"18769030\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Drosophila PHM (the rate-limiting enzyme of C-terminal α-amidation, ortholog of the PHM domain of PAM) is required for production of amidated neuropeptides and for normal developmental transitions. PHM null mutants lack PHM enzyme activity and amidated peptides, but retain peptide precursors and non-amidated neuropeptides. Rescue experiments demonstrate PHM is required throughout the life cycle, particularly during larval molting and metamorphosis, phenotypes resembling ecdysone-response gene mutations.\",\n      \"method\": \"Genetic null mutants, enzyme activity assay, immunostaining for neuropeptide products, transgenic rescue\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — genetic loss-of-function with direct enzymatic assay and defined peptide biosynthesis phenotype, ortholog study\",\n      \"pmids\": [\"10993678\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"PAM (MYCBP2) mRNA is highly and selectively expressed in pyramidal cells of the hippocampus, granule cells of the dentate gyrus, and cerebellum in the rodent brain. Expression is turned on after birth, upregulated during the first two postnatal weeks, and maintained into adulthood. No alteration in PAM expression is detected in mice lacking adenylyl cyclase type I or type VIII.\",\n      \"method\": \"In situ hybridization, developmental expression analysis, adenylyl cyclase knockout mouse comparison\",\n      \"journal\": \"Brain research. Developmental brain research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — direct localization by in situ hybridization with adenylyl cyclase knockout comparison; functional consequence not established\",\n      \"pmids\": [\"12036515\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Germline loss-of-function variants in the PAM gene (encoding peptidylglycine α-amidating monooxygenase) are enriched in subjects with pituitary hypersecretion. Missense and truncating PAM variants identified in pituitary adenoma patients reduce PAM protein expression and/or amidation activity in vitro, as confirmed by Western blotting, minigene splicing assays, and amidation activity assays in cell lysates and serum.\",\n      \"method\": \"Germline sequencing, Western blotting, minigene splicing assay, amidation activity assay in cell lysates and serum\",\n      \"journal\": \"Frontiers in endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional validation of multiple variants by enzymatic assay and expression analysis, single study\",\n      \"pmids\": [\"37388215\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"PAM (peptidylglycine α-amidating monooxygenase/MYCBP2) is a multifunctional type 1 integral membrane protein whose luminal domain harbors two catalytic activities (PHM and PAL) that sequentially amide the C-terminus of secretory peptides using copper, ascorbate, and O2; its cytosolic domain undergoes Uhmk1-dependent phosphorylation and proteolytic release to signal retrogradely to the nucleus, while its RING-domain-containing scaffold recruits FBXO45 and SKP1 to form an atypical SCF E3 ligase that ubiquitinates substrates including NMNAT2 and Rev-erbα, and its RCC1 domain directly binds and activates the KCC2 chloride cotransporter, collectively linking secretory peptide biosynthesis, circadian regulation, adenylyl cyclase inhibition via plasma membrane translocation, and synaptic development.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\nI'll classify each paper first, then extract discoveries only from KEEP papers.\n\n**Classification:**\n\nThe target gene PAM here is the canonical human protein **Peptidylglycine α-Amidating Monooxygenase** (PAM/MYCBP2 dual identity — but reading carefully, the corpus includes papers about:\n1. PAM = Peptidylglycine α-Amidating Monooxygenase (PMID:8518727, 26667899, etc.) ✓ KEEP\n2. PAM = Protein Associated with Myc / MYCBP2 (PMID:20534529, 14559897, 29997255, 15257286, 12036515, 18769030) ✓ KEEP (same human gene symbol PAM/MYCBP2)\n3. PAM = protospacer adjacent motif (CRISPR context) — EXCLUDE (alias collision)\n4. PAM = Streptococcus pyogenes M-like protein PAM (PMID:8244975, 9497374) — EXCLUDE (bacterial virulence protein, not human gene)\n5. PAL = phenylalanine ammonia-lyase (plant enzyme) — EXCLUDE\n6. PAL = peptidyl-α-hydroxyglycine α-amidating lyase (domain of PAM enzyme) — KEEP when in context of PAM protein\n7. PHM = peptidylglycine α-hydroxylating monooxygenase (domain of PAM) — KEEP when in context of PAM protein\n8. PHM = peptide histidine methionine (VIP-related peptide) — EXCLUDE\n9. PAL = peptidoglycan-associated lipoprotein (bacterial) — EXCLUDE\n10. PAM-1 antibody/aminopeptidase/other — evaluate case by case\n\nLet me go through each:\n\n- PMID:26098369 — CRISPR PAM → EXCLUDE\n- PMID:29512652 — CRISPR PAM → EXCLUDE\n- PMID:25079318 — CRISPR PAM → EXCLUDE\n- PMID:28581492 — CRISPR PAM → EXCLUDE\n- PMID:27041224 — CRISPR PAM → EXCLUDE\n- PMID:27984729 — CRISPR PAM → EXCLUDE\n- PMID:33483498 — CRISPR PAM → EXCLUDE\n- PMID:8244975 — bacterial PAM protein → EXCLUDE\n- PMID:30109815 — CRISPR PAM → EXCLUDE\n- PMID:15036564 — oxidative stress/apoptosis, no PAM → EXCLUDE\n- PMID:18679731 — plant PAL → EXCLUDE\n- PMID:27916599 — CRISPR PAM → EXCLUDE\n- PMID:28652856 — photo-affinity labeling PAL → EXCLUDE\n- PMID:26990991 — CRISPR PAM → EXCLUDE\n- PMID:2318966 — PAM 212 keratinocyte cell line, not PAM gene → EXCLUDE\n- PMID:32393822 — CRISPR PAM → EXCLUDE\n- PMID:32472934 — Tol-Pal bacterial → EXCLUDE\n- PMID:29512652 — already excluded\n- PMID:32424114 — CRISPR PAM → EXCLUDE\n- PMID:30928636 — CRISPR PAM/rice → EXCLUDE\n- PMID:20534529 — Pam/MYCBP2 as E3 ligase for Rev-erbα → KEEP\n- PMID:2987932 — PHM-27/VIP peptide → EXCLUDE\n- PMID:29883605 — CRISPR Cas4/PAM → EXCLUDE\n- PMID:10993678 — Drosophila PHM (α-amidating enzyme domain) → KEEP (ortholog context of PAM amidation)\n- PMID:26667899 — PAM amidating monooxygenase review → KEEP\n- PMID:14559897 — Pam/MYCBP2 interacts with TSC1/TSC2 → KEEP\n- PMID:22759610 — plant PAL → EXCLUDE\n- PMID:29941359 — plant PAL/PKU therapy → EXCLUDE\n- PMID:9497374 — bacterial PAM streptococcal → EXCLUDE\n- PMID:3018707 — PHM VIP receptors → EXCLUDE\n- PMID:32130891 — CRISPR PAM → EXCLUDE\n- PMID:6086627 — PHM-27/VIP → EXCLUDE\n- PMID:33547443 — CRISPR PAM → EXCLUDE\n- PMID:20573687 — PAM amidating enzyme signaling → KEEP\n- PMID:35552388 — CRISPR PAM → EXCLUDE\n- PMID:30937444 — CRISPR Cas4/PAM → EXCLUDE\n- PMID:10987251 — PHM partial hydatidiform mole → EXCLUDE\n- PMID:32329776 — CRISPR Cas12a PAM → EXCLUDE\n- PMID:31342294 — bacterial Pal vaccine → EXCLUDE\n- PMID:33636398 — CRISPR PAM → EXCLUDE\n- PMID:26354441 — Tol-Pal bacterial → EXCLUDE\n- PMID:26070140 — plant PAL → EXCLUDE\n- PMID:33974322 — plant PAL → EXCLUDE\n- PMID:32070055 — PAM pathway = PI3K/AKT/mTOR, not PAM gene → EXCLUDE\n- PMID:31655558 — fungal pal → EXCLUDE\n- PMID:23017408 — cyanobacteria PAL → EXCLUDE\n- PMID:29997255 — PAM/MYCBP2 SCF ubiquitin ligase → KEEP\n- PMID:26754817 — fungal Pal pathway → EXCLUDE\n- PMID:23392249 — CRISPR PAM archaea → EXCLUDE\n- PMID:22349733 — plant PAL → EXCLUDE\n- PMID:35308353 — Tol-Pal bacterial → EXCLUDE\n- PMID:15719499 — PAM-1 antibody/CFR-1 receptor → EXCLUDE (different entity)\n- PMID:21155570 — mGluR2 PAM (positive allosteric modulator) → EXCLUDE\n- PMID:2839091 — PHM-27/VIP gene → EXCLUDE\n- PMID:35797934 — CRISPR PAM → EXCLUDE\n- PMID:34687846 — CRISPR Cas12a PAM → EXCLUDE\n- PMID:34824292 — CRISPR PAM → EXCLUDE\n- PMID:33420918 — CRISPR PAM → EXCLUDE\n- PMID:6548020 — PHM-27/VIP → EXCLUDE\n- PMID:24173806 — Arabidopsis PAL OF QUIRKY → EXCLUDE\n- PMID:36247561 — wheat PAL → EXCLUDE\n- PMID:2366002 — PAL-M1 antibody/transferrin receptor → EXCLUDE\n- PMID:37697004 — CRISPR Cas12f PAM → EXCLUDE\n- PMID:29885909 — PAM-antagonist pharmacology → EXCLUDE\n- PMID:8020060 — PHM/VIP mRNA GI tract → EXCLUDE\n- PMID:11985791 — PAL = pyothorax-associated lymphoma → EXCLUDE\n- PMID:20599902 — PAM-1 aminopeptidase C. elegans → EXCLUDE (different gene, aminopeptidase)\n- PMID:29037946 — M4 PAM pharmacology → EXCLUDE\n- PMID:33679835 — plant PAL → EXCLUDE\n- PMID:38010352 — CRISPR PAM → EXCLUDE\n- PMID:37814209 — plant PAL → EXCLUDE\n- PMID:36581623 — plant PAL → EXCLUDE\n- PMID:37903458 — plant PAL → EXCLUDE\n- PMID:37388215 — PAM amidating monooxygenase pituitary → KEEP\n- PMID:13 (corpus) — CRISPR PAM → EXCLUDE\n- PMID:40262634 — CRISPR PAM → EXCLUDE\n- PMID:31036811 — CRISPR PAM → EXCLUDE\n- PMID:38942756 — CRISPR PAM → EXCLUDE\n- PMID:36268581 — CRISPR PAM → EXCLUDE\n- PMID:33441553 — CRISPR PAM → EXCLUDE\n- PMID:18769030 — PAM RCC1 domain/KCC2 → KEEP\n- PMID:39003282 — CRISPR PAM → EXCLUDE\n- PMID:28344037 — CRISPR PAM → EXCLUDE\n- PMID:8844771 — PHM/VIP peptides → EXCLUDE\n- PMID:37794046 — CRISPR PAM → EXCLUDE\n- PMID:30445722 — pneumococcal Pal endolysin → EXCLUDE\n- PMID:31603896 — CRISPR PAM → EXCLUDE\n- PMID:32241913 — CRISPR PAM → EXCLUDE\n- PMID:32494703 — CRISPR PAM → EXCLUDE\n- PMID:34874112 — CRISPR PAM → EXCLUDE\n- PMID:35335056 — Tol/Pal bacterial → EXCLUDE\n- PMID:36378874 — CRISPR PAM → EXCLUDE\n- PMID:35666156 — CRISPR PAM → EXCLUDE\n- PMID:31400605 — CRISPR PAM → EXCLUDE\n- PMID:10515919 — bacterial PAL peptidoglycan-associated → EXCLUDE\n- PMID:2422707 — PHM/VIP peptides → EXCLUDE\n- PMID:3840886 — PHM/VIP → EXCLUDE\n- PMID:1662940 — pAM beta1 plasmid → EXCLUDE\n- PMID:6086627 — already excluded\n- PMID:31101493 — Pam3CSK4 TLR2 → EXCLUDE\n\n**Additional gene2pubmed papers:**\n- PMID:17081983 — phosphoproteomics, mentions PAM phosphorylation → KEEP (phosphorylation site data)\n- PMID:12477932 — MGC cDNA project → EXCLUDE\n- PMID:19571808 — schizophrenia GWAS → EXCLUDE\n- PMID:26186194 — BioPlex interactome → KEEP (PAM interactions)\n- PMID:28514442 — BioPlex 2.0 → KEEP (PAM interactions)\n- PMID:33961781 — BioPlex 3.0 → KEEP (PAM interactions)\n- PMID:21873635 — GO annotation → EXCLUDE\n- PMID:15489334 — MGC cDNA → EXCLUDE\n- PMID:16344560 — alternative promoters → EXCLUDE\n- PMID:19199708 — salivary proteomics → EXCLUDE\n- PMID:24464100 — T2D risk variants in PAM → KEEP (functional variants)\n- PMID:20351714 — MDD GWAS → EXCLUDE\n- PMID:8518727 — PAM multifunctional protein → KEEP\n- PMID:15840729 — calmodulin binding → EXCLUDE (not specifically PAM)\n- PMID:23533145 — prostate exosome proteomics → EXCLUDE\n- PMID:23376485 — podocyte exosome proteomics → EXCLUDE\n- PMID:9139723 — Kalirin/P-CIP10 interacts with PAM cytosolic domain → KEEP\n- PMID:20379614 — smoking cessation genetics → EXCLUDE\n- PMID:26879543 — copper flow/neuronal differentiation, mentions PAM → KEEP\n- PMID:30054598 — T2D risk alleles in PAM → KEEP\n- PMID:28700943 — K-Ras CRISPR screen → EXCLUDE\n- PMID:2357221 — human PAM cDNA cloning → KEEP\n- PMID:29987050 — PAK2 in breast cancer, mentions PAM pathway → EXCLUDE (PAM here = PI3K pathway)\n- PMID:1448112 — PAM gene exon/intron organization → KEEP\n- PMID:36138187 — NUDT21/CD19 leukemia → EXCLUDE\n- PMID:8486658 — PAM catalytic domains/endoproteolysis → KEEP\n- PMID:9110174 — brain cDNA sequencing → EXCLUDE\n- PMID:8530412 — phosphorylation of PAM cytosolic domain → KEEP\n- PMID:9837933 — P-CIP1 interacts with PAM cytosolic domain → KEEP\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1990,\n      \"finding\": \"Human PAM (peptidylglycine α-amidating monooxygenase) cDNA was cloned from a thyroid carcinoma library. A truncated form lacking the C-terminal transmembrane domain was functionally expressed in COS cells, producing a soluble, active enzyme with a 20-fold increase in amidating activity over controls, establishing that the transmembrane domain is dispensable for catalytic activity.\",\n      \"method\": \"cDNA cloning, heterologous expression in COS cells, enzyme activity assay\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — functional expression with activity measurement; single lab study\",\n      \"pmids\": [\"2357221\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"The rat PAM gene consists of 27 exons spanning >160 kb. Alternative splicing within the PHM region generates soluble monofunctional PHM proteins; alternative splicing at the transmembrane domain exon generates integral membrane or soluble bifunctional PAM proteins; and a single alternatively spliced exon between PHM and PAL domains permits endoproteolytic separation of the two catalytic activities. The human PAM gene was mapped to chromosome 5q.\",\n      \"method\": \"Genomic cloning, Southern blotting, exon mapping, hybrid cell panel analysis\",\n      \"journal\": \"Molecular endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct genomic and cDNA structural analysis with functional annotation; replicated across species\",\n      \"pmids\": [\"1448112\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"PAM is a multifunctional type-1 integral membrane protein containing two sequential catalytic domains: peptidylglycine α-hydroxylating monooxygenase (PHM), which performs copper- and ascorbate-dependent α-hydroxylation of peptidylglycine substrates, and peptidyl-α-hydroxyglycine α-amidating lyase (PAL), which cleaves the N–C bond to produce amidated peptide and glyoxylate. Tissue-specific alternative splicing generates integral membrane or soluble forms, and the cytosolic C-terminal domain contains routing information for retrieval from the cell surface.\",\n      \"method\": \"Protein purification, enzyme assays, alternative splicing analysis, transfected cell expression\",\n      \"journal\": \"Protein science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — biochemical reconstitution of two-step reaction with domain identification; foundational review synthesizing multiple experiments\",\n      \"pmids\": [\"8518727\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"Endoproteolytic removal of the C-terminal region from bifunctional soluble PAM-3 (PHM+PAL) shifted the PHM pH optimum to more alkaline, increased PHM kcat, and decreased its Km for peptidylglycine substrate, while PAL activity was unaffected. This demonstrated that the PAL domain and C-terminal region modulate PHM catalytic properties within the bifunctional protein.\",\n      \"method\": \"Protein purification from transfected HEK-293 cells, limited endoproteolysis, N-terminal sequencing, enzyme kinetics\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro biochemical assay with defined proteolytic manipulation and kinetic measurements\",\n      \"pmids\": [\"8486658\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"The cytosolic domain of integral membrane PAM is phosphorylated on Ser932 and Ser937 by protein kinase C (PKC). Phosphorylation at Ser937 is required for correct post-endocytic routing of PAM: a Ser937→Ala mutant is abnormally targeted to lysosomes upon internalization rather than being recycled, establishing a role for PKC-mediated phosphorylation in PAM trafficking.\",\n      \"method\": \"Metabolic [32P] labeling, truncation mutagenesis, site-directed mutagenesis (Ser937→Ala), subcellular fractionation, PAM antibody internalization assay in AtT-20 and HEK-293 cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — mutagenesis combined with functional trafficking readout in endocrine cells\",\n      \"pmids\": [\"8530412\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Using yeast two-hybrid screening, the cytosolic routing domain of PAM was found to interact with P-CIP10 (later named Kalirin), a 217-kDa cytosolic protein containing nine spectrin-like repeats and Dbl homology/pleckstrin homology domains typical of GDP/GTP exchange factors. Kalirin binds Rac1 but not RhoA or Cdc42, and co-expression with PAM in corticotrope tumor cells accelerates PAM turnover and promotes longer, more branched neuritic processes, suggesting Kalirin links PAM lumenal activity to cytoskeletal regulation.\",\n      \"method\": \"Yeast two-hybrid, GST pull-down, co-expression in AtT-20 cells, neurite morphology assay, GTPase binding assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — yeast two-hybrid confirmed by pull-down with functional cellular phenotype; multiple orthogonal methods\",\n      \"pmids\": [\"9139723\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"P-CIP1, a novel 435-amino-acid cytosolic protein identified by yeast two-hybrid as a PAM cytosolic domain interactor, associates specifically with wild-type PAM-1 but not with trafficking-defective PAM-1 mutants. P-CIP1 localizes to recycling endosomes (overlapping with secretory carrier membrane proteins, transferrin, and Rab11), suggesting it regulates PAM trafficking through the endosomal pathway.\",\n      \"method\": \"Yeast two-hybrid, in vitro pull-down, co-expression in endocrine and fibroblast cells, immunofluorescence colocalization with endosomal markers\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — yeast two-hybrid with localization data; no direct rescue experiment\",\n      \"pmids\": [\"9837933\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"In Drosophila, PHM (the α-hydroxylating monooxygenase domain/activity of PAM) is the rate-limiting enzyme for C-terminal α-amidation of neuropeptides. PHM null mutants lack amidated peptides but retain non-amidated neuropeptide precursors and other biosynthetic enzymes. PHM mutants display phenotypes resembling ecdysone-response gene mutations, including failure to molt and pupal lethality, establishing that PHM-dependent peptide amidation is essential for developmental transitions between stages.\",\n      \"method\": \"Genetic null mutants, enzyme activity assay, neuropeptide immunostaining, transgenic rescue with inducible PHM transgene\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — genetic null with biochemical validation and transgenic rescue in Drosophila ortholog\",\n      \"pmids\": [\"10993678\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Pam (PAM/MYCBP2) was found to associate with the tuberin–hamartin (TSC2–TSC1) complex in rat brain. The C-terminus of Pam containing the RING zinc finger domain binds directly to tuberin. In cortical neurons, Pam co-localizes with tuberin and hamartin in neurites and growth cones. Genetic studies in Drosophila showed that the Pam ortholog Highwire (HIW) can negetically interact with the Tsc1·Tsc2 complex, consistent with PAM acting as a potential E3 ubiquitin ligase that regulates TSC1/TSC2 complex stability.\",\n      \"method\": \"Co-immunoprecipitation from rat brain, yeast two-hybrid domain mapping, immunofluorescence colocalization in cortical neurons, Drosophila genetic epistasis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — Co-IP plus genetic epistasis but ubiquitin ligase activity not directly reconstituted\",\n      \"pmids\": [\"14559897\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"PAM (Protein Associated with Myc/MYCBP2) is localized to the endoplasmic reticulum in HeLa cells. Treatment with sphingosine-1-phosphate (S1P), purified from serum, induces translocation of PAM to the plasma membrane within 15 min, persisting up to 120 min. This PAM translocation mediates a late phase (20–240 min) of adenylyl cyclase inhibition that is PAM-dependent, distinct from an early Gi-mediated phase. Thus PAM acts as the longest-lasting non-transcriptional inhibitor of adenylyl cyclase activity known, enabling sustained inhibition of cAMP signaling.\",\n      \"method\": \"Subcellular fractionation, immunofluorescence microscopy, adenylyl cyclase activity assay, S1P purification, siRNA knockdown\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct localization experiment with functional consequence (adenylyl cyclase inhibition), siRNA validation, multiple orthogonal methods\",\n      \"pmids\": [\"15257286\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"The RCC1 (Regulator of Chromatin Condensation) domain of PAM (MYCBP2) was identified as a binding partner of the K+/Cl− cotransporter KCC2 via yeast two-hybrid screening. The RCC1 domain of PAM binds to a 20-amino-acid region on the KCC2 C-terminus, as confirmed by GST pull-down and co-immunoprecipitation in HEK293 cells. Co-expression of RCC1/PAM with KCC2 increases KCC2-mediated 86Rb+/K+ flux, and a point mutant in the KCC2 binding region abolishes both PAM interaction and N-ethylmaleimide activation of KCC2, establishing PAM as a positive modulator of KCC2 cotransporter function.\",\n      \"method\": \"Yeast two-hybrid, GST pull-down, co-immunoprecipitation in HEK293, 86Rb+/K+ uptake assay, site-directed mutagenesis\",\n      \"journal\": \"Cellular physiology and biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal binding assays plus functional transport assay with mutagenesis validation\",\n      \"pmids\": [\"18769030\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"E3 ligases Arf-bp1 and Pam (MYCBP2) co-purify with the circadian heme receptor Rev-erbα and are required for its ubiquitination and proteasomal degradation. RNAi-mediated depletion of Arf-bp1 or Pam stabilizes Rev-erbα protein and protects it from degradation triggered by lithium (a GSK3β inhibitor) or serum shock. This degradation pathway controls expression of Rev-erbα-regulated clock genes including Bmal1 and modulates circadian function in mouse hepatoma cells.\",\n      \"method\": \"Affinity purification/co-IP, ubiquitination assay, RNAi knockdown, cycloheximide chase, circadian gene expression analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP, ubiquitination assay, and RNAi functional rescue with circadian phenotype; multiple orthogonal methods\",\n      \"pmids\": [\"20534529\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"The cytosolic domain (CD) of PAM (amidating monooxygenase) is phosphorylated by U2AF homology motif kinase 1 (Uhmk1/J83). Uhmk1 is concentrated in the nucleus but cycles rapidly between nucleus and cytosol. Endoproteolytic cleavage of integral membrane PAM releases a soluble CD fragment that localizes to the nucleus. Phosphomimetic mutations in PAM-CD or overexpression of active Uhmk1 reduces nuclear localization of PAM-CD. Nuclear PAM-CD increases expression of a subset of genes including aquaporin 1 (Aqp1); this relationship is confirmed in vivo in PAM heterozygous mice. Thus, a retrograde signaling pathway exists from secretory granules to the nucleus via PAM-CD cleavage.\",\n      \"method\": \"Subcellular fractionation, phosphomimetic mutagenesis, Uhmk1 overexpression/knockdown, microarray gene expression analysis, in vivo PAM heterozygous mouse model\",\n      \"journal\": \"Molecular endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods including mutagenesis, in vivo validation in heterozygous mice, and microarray; moderate-strong evidence\",\n      \"pmids\": [\"20573687\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"PAM (amidating monooxygenase) is an evolutionarily ancient bifunctional enzyme: the PHM domain uses copper, ascorbate (vitamin C), and molecular oxygen to hydroxylate the Cα of C-terminal glycine-extended peptide substrates; the PAL domain then cleaves the N–Cα bond to yield amidated product and glyoxylate. Crystal structures of both catalytic cores have been determined, revealing metal-coordination and substrate-binding mechanisms. PAM is also found in cilia and in Chlamydomonas (a unicellular eukaryote), indicating a role beyond peptide processing. The cytosolic domain, though intrinsically disordered, is essential for PAM trafficking. Evidence also supports a role for PAM in copper homeostasis and in retrograde signaling from the secretory pathway lumen to the nucleus.\",\n      \"method\": \"Crystal structure determination, enzymatic assays, knockout mouse model (lethal at mid-gestation), phylogenetic survey, cellular localization studies\",\n      \"journal\": \"Journal of molecular endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structures plus multiple in vivo and biochemical validations; comprehensive review of original experimental findings\",\n      \"pmids\": [\"26667899\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Neuronal differentiation increases copper demand within the secretory pathway. This is facilitated in part by upregulation of the copper transporter ATP7A and its chaperone Atox1. PAM (peptidylglycine α-amidating monooxygenase), a copper-dependent enzyme in the secretory pathway, is among the copper-dependent enzymes whose expression is elevated in differentiated neurons, directly linking copper availability to PAM-dependent amidation capacity.\",\n      \"method\": \"Quantitative real-time imaging of copper/glutathione redox state, qPCR, western blotting in differentiating neuronal cells\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — expression upregulation measured in differentiation context; PAM's copper dependency established but mechanism not directly probed in this study\",\n      \"pmids\": [\"26879543\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"PAM (MYCBP2) forms a noncanonical SCF-like ubiquitin ligase complex containing FBXO45 and SKP1 but lacking CUL1. FBXO45 is required for assembly of the PAM/FBXO45/SKP1 complex, not merely for substrate recognition. SKP1 acts as an auxiliary component of the substrate recognition module, enhancing FBXO45 binding to NMNAT2. PAM polyubiquitinates NMNAT2 and promotes its proteasomal degradation, establishing the biochemical mechanism by which PAM/PHR proteins regulate axon degeneration through NMNAT2.\",\n      \"method\": \"Affinity purification/co-immunoprecipitation, in vitro ubiquitination assay, proteasome inhibitor treatment, cycloheximide chase, domain-specific interaction mapping in C. elegans and human cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vitro ubiquitination assay plus Co-IP complex characterization and degradation assay; multiple orthogonal methods\",\n      \"pmids\": [\"29997255\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Missense variants in PAM (amidating monooxygenase) — p.Asp563Gly and p.Ser539Trp — are associated with type 2 diabetes risk and impact negatively on overall PAM amidating activity via defects in protein expression and catalytic function. PAM deficiency in a human β-cell model and primary cadaveric islets reduces insulin content and alters dynamics of insulin secretion, establishing a direct role for PAM-mediated peptide amidation in β-cell function.\",\n      \"method\": \"Functional variant analysis (Western blot, amidation activity assay in cell lysates and serum), human β-cell model (EndoC-βH1), primary human islets, insulin secretion assay\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — direct enzymatic activity measurement, loss-of-function in human β-cells and primary islets, multiple orthogonal methods\",\n      \"pmids\": [\"30054598\", \"24464100\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Germline loss-of-function variants in PAM (amidating monooxygenase) are enriched in individuals with pituitary hypersecretion (including growth hormone excess and Cushing disease). Seven heterozygous likely pathogenic SNVs were identified and functionally validated: in vitro assays showed reduced protein expression, abnormal splicing (minigene assay), and decreased amidating activity in cell lysates and patient serum, confirming deleterious effects on PAM function and linking PAM to pituitary tumor/hypersecretion pathogenesis.\",\n      \"method\": \"Germline sequencing, CNV analysis, Western blotting, minigene splicing assay, amidation activity assay in cell lysates and serum, UK Biobank exome analysis\",\n      \"journal\": \"Frontiers in endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple functional validation methods across several variants; large-scale epidemiological confirmation in UK Biobank\",\n      \"pmids\": [\"37388215\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"PAM encodes a bifunctional, copper- and ascorbate-dependent type-1 integral membrane enzyme whose luminal PHM domain hydroxylates C-terminal glycine-extended peptide substrates and whose PAL domain cleaves the product to yield amidated peptides and glyoxylate; its intrinsically disordered cytosolic domain is phosphorylated by PKC (on Ser937, governing endosomal recycling) and by Uhmk1, interacts with trafficking proteins (Kalirin/P-CIP10, P-CIP1) and KCC2, and can be endoproteolytically released to signal retrogradely to the nucleus; the MYCBP2/PAM paralog (Protein Associated with Myc) functions as a non-canonical SCF E3 ubiquitin ligase (with FBXO45/SKP1 but lacking CUL1) that polyubiquitinates NMNAT2 to regulate axon degeneration, inhibits adenylyl cyclase activity downstream of sphingosine-1-phosphate signaling, targets Rev-erbα for degradation to modulate circadian rhythms, and interacts with the TSC1–TSC2 complex; loss-of-function variants in the amidating PAM reduce β-cell insulin content and are associated with type 2 diabetes and pituitary hypersecretion.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"PAM (peptidylglycine α-amidating monooxygenase) is the sole enzyme responsible for C-terminal α-amidation of secretory peptides, a modification essential for the bioactivity of numerous neuropeptides and peptide hormones. Its luminal domain contains two sequential catalytic activities: PHM (peptidylglycine α-hydroxylating monooxygenase), which uses copper, ascorbate, and molecular oxygen to hydroxylate the peptidylglycine substrate, and PAL (peptidyl-α-hydroxyglycine α-amidating lyase), which cleaves the hydroxylated intermediate to yield the amidated peptide and glyoxylate; crystal structures of both domains have been determined [PMID:26667899]. Genetic ablation of PHM in Drosophila eliminates amidated neuropeptides and causes lethal developmental defects resembling ecdysone pathway disruption [PMID:10993678], and human germline loss-of-function PAM variants are enriched in pituitary hypersecretion, with affected variants showing reduced amidation activity in vitro [PMID:37388215]. Beyond its enzymatic function, the cytosolic domain of PAM undergoes Uhmk1-dependent phosphorylation and endoproteolytic release, enabling retrograde nuclear translocation that modulates gene expression including Aqp1 [PMID:20573687].\",\n  \"teleology\": [\n    {\n      \"year\": 2000,\n      \"claim\": \"Genetic loss-of-function of the PHM domain in Drosophila established that α-amidation is essential for neuropeptide bioactivity and organismal viability, answering whether the enzymatic activity is dispensable or required in vivo.\",\n      \"evidence\": \"PHM null mutant flies lacking amidated peptides with transgenic rescue in Drosophila\",\n      \"pmids\": [\"10993678\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mammalian in vivo requirement not tested in this study\", \"Which specific amidated peptides mediate the developmental phenotype unclear\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Demonstration that PAM (MYCBP2) mRNA is selectively expressed in hippocampal and cerebellar neurons with postnatal upregulation established its neuron-enriched expression pattern, raising the question of its neuronal function beyond peptide amidation.\",\n      \"evidence\": \"In situ hybridization across postnatal rodent brain development\",\n      \"pmids\": [\"12036515\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Expression data only; no functional consequence demonstrated\", \"Protein-level localization not shown\", \"Relationship between MYCBP2 and the amidating enzyme PAM gene identity is ambiguous in the original source\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Discovery that PAM (MYCBP2) physically associates with the TSC1-TSC2 tumor suppressor complex via its RING domain identified a scaffold function beyond ubiquitin ligase activity, connecting PAM to growth signaling in neurons.\",\n      \"evidence\": \"Co-immunoprecipitation, domain mapping, and Drosophila Highwire genetic epistasis\",\n      \"pmids\": [\"14559897\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct ubiquitination of TSC1/TSC2 by PAM not demonstrated\", \"Functional consequence of PAM-TSC2 interaction on mTOR signaling not biochemically resolved\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Showing that PAM (MYCBP2) translocates from the ER to the plasma membrane upon S1P stimulation to inhibit adenylyl cyclase revealed a non-transcriptional mechanism for sustained cAMP suppression.\",\n      \"evidence\": \"Subcellular fractionation, immunofluorescence, adenylyl cyclase activity assay, and RNAi in HeLa cells\",\n      \"pmids\": [\"15257286\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular mechanism by which PAM inhibits adenylyl cyclase at the plasma membrane unknown\", \"Generality beyond HeLa and S1P stimulation not established\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Identification of the RCC1 domain of PAM (MYCBP2) as a direct activator of KCC2 chloride cotransporter linked PAM scaffold function to regulation of neuronal chloride homeostasis.\",\n      \"evidence\": \"Yeast two-hybrid, GST pulldown, co-IP, and 86Rb uptake assay with point mutagenesis in HEK293 cells\",\n      \"pmids\": [\"18769030\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo neuronal validation of PAM-KCC2 interaction not performed\", \"Whether PAM ubiquitin ligase activity also regulates KCC2 not tested\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Two parallel discoveries in 2010 established that (a) PAM (MYCBP2) functions as an E3 ubiquitin ligase targeting Rev-erbα for proteasomal degradation, directly linking it to circadian clock regulation, and (b) the cytosolic domain of the amidating enzyme PAM undergoes phosphorylation-regulated nuclear translocation to modulate gene expression, defining a retrograde secretory granule-to-nucleus signaling pathway.\",\n      \"evidence\": \"Co-purification with ubiquitination assays and RNAi for Rev-erbα degradation; Uhmk1 phosphorylation, nuclear fractionation, phosphomimetic mutagenesis, and PAM heterozygous knockout mice for retrograde signaling\",\n      \"pmids\": [\"20534529\", \"20573687\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis for PAM E3 ligase substrate selectivity unknown\", \"Whether retrograde signaling by PAM cytosolic domain feeds back on amidation capacity untested\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Crystal structures and reconstituted enzymatic activities of both PHM and PAL domains provided a complete mechanistic picture of the two-step amidation reaction, confirming copper- and ascorbate-dependent hydroxylation followed by lyase-mediated cleavage.\",\n      \"evidence\": \"X-ray crystallography, in vitro enzymatic assays, mutagenesis (comprehensive review of decades of biochemical work)\",\n      \"pmids\": [\"26667899\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No full-length PAM structure including transmembrane and cytosolic domains\", \"How membrane-anchored PAM coordinates its two catalytic activities in the secretory pathway not structurally resolved\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Reconstitution of a non-canonical SCF-like E3 ligase complex (PAM/FBXO45/SKP1 lacking CUL1) that polyubiquitinates NMNAT2 defined the architectural basis for PAM ubiquitin ligase activity and its role in axon degeneration pathways.\",\n      \"evidence\": \"Co-immunoprecipitation, in vitro ubiquitination reconstitution, domain mapping, proteasome inhibition in human cells\",\n      \"pmids\": [\"29997255\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How the atypical complex is recruited to additional substrates beyond NMNAT2 and Rev-erbα unknown\", \"Structural basis for CUL1-independent ubiquitin chain assembly not determined\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Enrichment of germline PAM loss-of-function variants in pituitary hypersecretion patients, with demonstrated reduction of amidation activity, established a human disease link and suggested that impaired peptide amidation contributes to pituitary pathology.\",\n      \"evidence\": \"Germline sequencing cohort, Western blotting, minigene splicing assays, and amidation activity assays in cell lysates and serum\",\n      \"pmids\": [\"37388215\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Causal mechanism from reduced amidation to pituitary hypersecretion not delineated\", \"Single cohort study; independent replication needed\", \"Which specific amidated peptide deficiencies drive the phenotype unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Major unresolved questions include the full-length structure of membrane-anchored PAM, the complete substrate repertoire of its E3 ligase activity, the mechanism by which retrograde nuclear signaling integrates with its enzymatic function, and whether PAM amidation deficiency directly causes defined Mendelian disease.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No full-length PAM structure\", \"Complete E3 ligase substrate repertoire unknown\", \"Integration of enzymatic amidation and retrograde signaling not mechanistically connected\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016491\", \"supporting_discovery_ids\": [0, 7]},\n      {\"term_id\": \"GO:0016829\", \"supporting_discovery_ids\": [0]},\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 7, 9]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [3]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [3]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [5]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": []},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [0, 7, 9]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [3, 5]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [6, 8]}\n    ],\n    \"complexes\": [\n      \"PAM/FBXO45/SKP1 atypical SCF-like E3 ligase\"\n    ],\n    \"partners\": [\n      \"FBXO45\",\n      \"SKP1\",\n      \"NMNAT2\",\n      \"UHMK1\",\n      \"TSC2\",\n      \"KCC2\",\n      \"NR1D1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"PAM (peptidyl-glycine alpha-amidating monooxygenase) is a bifunctional, copper- and ascorbate-dependent type-1 integral membrane enzyme that catalyzes the two-step C-terminal amidation of secretory peptides: its PHM domain α-hydroxylates glycine-extended substrates, and its PAL domain cleaves the intermediate to yield amidated peptide and glyoxylate [PMID:8518727, PMID:26667899]. Alternative splicing of the 27-exon gene generates soluble or membrane-anchored isoforms, and the intrinsically disordered cytosolic domain undergoes PKC-dependent phosphorylation at Ser937 to direct endosomal recycling rather than lysosomal degradation, while Uhmk1-mediated phosphorylation regulates nuclear import of an endoproteolytically released cytosolic fragment that activates gene expression retrogradely from secretory granules [PMID:8530412, PMID:20573687]. PAM-dependent peptide amidation is essential for insect development, mammalian embryogenesis, and pancreatic β-cell insulin content; loss-of-function variants reduce amidating activity and are associated with type 2 diabetes risk and pituitary hypersecretion [PMID:10993678, PMID:30054598, PMID:37388215].\",\n  \"teleology\": [\n    {\n      \"year\": 1990,\n      \"claim\": \"Cloning of human PAM cDNA and demonstration that a soluble truncated form retains full amidating activity established that the transmembrane domain is dispensable for catalysis, framing the protein as a modular enzyme.\",\n      \"evidence\": \"cDNA cloning from thyroid carcinoma library, heterologous expression in COS cells with enzyme activity assay\",\n      \"pmids\": [\"2357221\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab observation without independent replication at that time\", \"Physiological relevance of soluble forms unclear\"]\n    },\n    {\n      \"year\": 1992,\n      \"claim\": \"Genomic characterization revealed a 27-exon gene with extensive alternative splicing that generates soluble versus membrane-bound and monofunctional versus bifunctional isoforms, explaining the tissue-specific diversity of PAM products.\",\n      \"evidence\": \"Genomic cloning, exon mapping, and Southern blotting in rat; chromosomal mapping in human\",\n      \"pmids\": [\"1448112\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Tissue-specific splicing regulation mechanisms undefined\", \"Functional significance of each splice form not individually tested\"]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"Biochemical reconstitution defined the two-step reaction — PHM-catalyzed copper/ascorbate-dependent α-hydroxylation followed by PAL-catalyzed lyase cleavage — and showed that the PAL domain allosterically modulates PHM kinetics within the bifunctional protein.\",\n      \"evidence\": \"Protein purification, limited endoproteolysis, N-terminal sequencing, and enzyme kinetics in HEK-293 cells\",\n      \"pmids\": [\"8518727\", \"8486658\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No atomic-resolution structure at this stage\", \"In vivo relevance of intramolecular domain modulation not tested\"]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Identification of PKC-dependent phosphorylation at Ser937 as a trafficking switch — preventing lysosomal mis-sorting after endocytosis — established that the cytosolic domain actively controls PAM's itinerary through the endosomal system.\",\n      \"evidence\": \"Metabolic 32P labeling, Ser937→Ala mutagenesis, antibody internalization assay in AtT-20 and HEK-293 cells\",\n      \"pmids\": [\"8530412\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the phosphatase reversing Ser937 phosphorylation unknown\", \"Kinase specificity beyond PKC not explored\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Discovery that the PAM cytosolic domain binds Kalirin, a Rac1-specific GEF, linked luminal enzymatic processing to cytoskeletal remodeling and neurite morphogenesis, revealing a signaling role beyond peptide amidation.\",\n      \"evidence\": \"Yeast two-hybrid, GST pull-down, co-expression in AtT-20 cells with neurite morphology readout\",\n      \"pmids\": [\"9139723\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Kalirin interaction is direct or scaffolded in vivo not settled\", \"Rac1-dependent downstream effectors not mapped\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Identification of P-CIP1 as a second cytosolic-domain interactor localized to recycling endosomes extended the model that PAM's cytoplasmic tail coordinates vesicular trafficking.\",\n      \"evidence\": \"Yeast two-hybrid, pull-down, immunofluorescence colocalization with endosomal markers\",\n      \"pmids\": [\"9837933\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No direct rescue experiment to confirm functional role of P-CIP1 in PAM recycling\", \"Endogenous stoichiometry of P-CIP1–PAM complex not determined\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Genetic ablation of the Drosophila PHM ortholog proved that PHM-dependent amidation is essential for organism-level viability, with null mutants failing to complete developmental molting transitions.\",\n      \"evidence\": \"PHM null mutants, neuropeptide immunostaining, transgenic rescue in Drosophila\",\n      \"pmids\": [\"10993678\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific amidated peptide substrates driving lethality not identified\", \"Mammalian in vivo essentiality confirmed later but not here\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"The demonstration that endoproteolytic release of PAM's cytosolic domain allows nuclear translocation and gene regulation (e.g., Aqp1), modulated by Uhmk1 phosphorylation and confirmed in PAM heterozygous mice, established a retrograde secretory-granule-to-nucleus signaling pathway.\",\n      \"evidence\": \"Subcellular fractionation, phosphomimetic mutagenesis, microarray, PAM heterozygous mouse model\",\n      \"pmids\": [\"20573687\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full repertoire of nuclear gene targets unknown\", \"Mechanism of PAM-CD-dependent transcriptional activation unclear\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Crystal structures of both PHM and PAL catalytic cores resolved metal coordination and substrate-binding geometry; phylogenetic surveys extending to Chlamydomonas and cilia indicated PAM's evolutionary antiquity and roles beyond neuropeptide processing.\",\n      \"evidence\": \"X-ray crystallography, enzymatic assays, knockout mouse (mid-gestation lethal), phylogenetic analysis\",\n      \"pmids\": [\"26667899\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Ciliary function of PAM mechanistically uncharacterized\", \"How PAM contributes to copper homeostasis remains unclear\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Functional validation of PAM missense variants (p.Asp563Gly, p.Ser539Trp) linked reduced amidating activity to lower β-cell insulin content and type 2 diabetes risk, directly connecting PAM enzymology to metabolic disease.\",\n      \"evidence\": \"Variant activity assays, EndoC-βH1 human β-cell model, primary human islets, insulin secretion measurements\",\n      \"pmids\": [\"30054598\", \"24464100\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Which specific amidated peptides in β-cells are functionally critical remains undefined\", \"Heterozygous loss-of-function penetrance and modifier genes not characterized\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Enrichment of germline loss-of-function PAM variants in pituitary hypersecretion patients, validated by splicing and activity assays, expanded PAM's disease spectrum beyond diabetes to neuroendocrine tumor predisposition.\",\n      \"evidence\": \"Germline sequencing, minigene splicing assay, amidation activity assay, UK Biobank exome association\",\n      \"pmids\": [\"37388215\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism linking reduced amidation to pituitary hyperplasia/hypersecretion not delineated\", \"Whether somatic second hits contribute to tumorigenesis unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the identities of the specific amidated substrates driving β-cell and pituitary phenotypes, the molecular mechanism of PAM's ciliary function, and how the retrograde nuclear signaling pathway converges on transcription.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Critical amidated substrates in β-cells and pituitary not identified\", \"PAM ciliary function mechanistically undefined\", \"Transcription factor partners of nuclear PAM-CD unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016491\", \"supporting_discovery_ids\": [0, 2, 3, 7, 13, 16]},\n      {\"term_id\": \"GO:0016829\", \"supporting_discovery_ids\": [2, 3, 13]},\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [2, 13]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [1, 2, 4]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [4, 6]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [12]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [4, 6, 12, 13]},\n      {\"term_id\": \"GO:0005929\", \"supporting_discovery_ids\": [13]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [2, 3, 13, 16]},\n      {\"term_id\": \"R-HSA-9609507\", \"supporting_discovery_ids\": [4, 6, 12]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [7]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [16, 17]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [5, 12]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"KALRN\",\n      \"PCIP1\",\n      \"UHMK1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}